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Introduction 
It is well established that physical activity is an important factor related to health and 
well-being. Currently, the leading health institutions and associations, including the US 
Department of Health and Human Services (USDHHS), the American Heart Association 
(AHA), the American College of Sports Medicine (ACSM), the American Diabetes 
Association (ADA) and the American Cancer Society (ACS), recommend 150 minutes of 
moderate intensity, or 75 minutes of high intensity, physical activity per week (Colberg et 
al., 2010, 2016; Kushi et al., 2012). The current physical activity recommendations are 
based on a thorough body of evidence that demonstrates the positive effect of physical 
activity on a wide variety of health outcomes, including all-cause mortality, 
cardiovascular disease, stroke, type II diabetes mellitus, Alzheimer’s disease, depression 
and breast and colon cancer (Aune, Norat, Leitzmann, Tonstad, & Vatten, 2015; Hamer 
& Chida, 2009; Johnson et al., 2013; Kyu et al., 2016; Lear et al., 2017; Sattelmair et al., 
2011; Silveira et al., 2013; Wu, Zhang, & Kang, 2013). With this understanding in mind, 
it is surprising to find out that a majority of Americans fail to meet the recommendations 
for weekly physical activity (Troiano et al., 2008; Tucker, Welk, & Beyler, 2011; US 
Department of Health and Human Services, 2014).  
The Exercise is Medicine® (EIM®) initiative, was developed in an effort to increase 
population physical activity through primary care practitioner action, in 2007. However, 
there is little evidence to suggest that it has been successful thus far. The general research 
question that this dissertation aims to address is, “how can the clinical Exercise is 
Medicine® model be integrated more effectively into the current medical system?  
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To answer this question, three studies were performed. First an updated economic 
analysis of the effects of physical inactivity on the US healthcare system was carried out 
in order to answer the question, “is it worth it to implement a physical activity 
intervention such as the EIM®?” It was hypothesized that the annual direct medical costs 
of physical inactivity would rival those of tobacco, and that the accomplishment of the 
Healthy People 2020 objective of increasing population physical activity levels by 10% 
would result in meaningful reductions in terms of caseload and direct medical costs. 
Second, a survey Assessment of Providers’ Knowledge and Understanding of the 
American College of Sports Medicine Exercise is Medicine® Initiative, was distributed 
to over 10,000 primary care practitioners in order to gain a better understanding of the 
current state of the EIM® strategy from the perspective of the primary care practitioner. 
It was hypothesized that primary care practitioners are not aware of the EIM® initiative, 
are not regularly implementing all of the steps of the EIM® process with their patient 
populations, do think that the steps of the EIM® process fall within their scope of 
practice and do believe that implementation of the EIM® initiative will increase 
population physical activity levels. Third, A Critical Evaluation of the Exercise is 
Medicine® Initiative with Proposed Amendments assesses each individual step of the 
EIM® process and the evidence on which it is based. From this assessment strengths and 
weaknesses of the process are highlighted and recommendations for improvement are 
made. 
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Physical Activity Recommendations  
Physical Activity, Physical Inactivity and Sedentary Behavior 
Physical activity has been defined as any bodily movement that involves skeletal muscle 
and energy expenditure. Exercise is considered a subset classification of physical activity, 
in which the undertaken physical activity is purposeful, structured and repetitive 
(Caspersen et al., 1985; González, Fuentes, & Márquez, 2017).  
Physical inactivity can be defined as a failure to accomplish the recommended weekly 
levels of physical activity, whereas, sedentary behavior is any behavior that requires less 
than or equal to 1.5 metabolic equivalents (González et al., 2017; Sedentary Behaviour 
Research Network, 2012). This dissertation focuses on the difference between physically 
active vs. physically inactive individuals, meaning the difference between those that do, 
and do not, accomplish the recommended weekly levels of physical activity. There is no 
commentary on levels of sedentary behavior accrued by either population. 
 
Physical Activity Recommendations Past to Present 
In 1995 the Centers for Disease Control and the American College of Sports Medicine 
issued a joint statement in which they recommended the accumulation of greater than 30 
minutes of moderate or higher intensity activity on more than five days per week, based 
on observational and experimental studies that demonstrated positive health related 
outcomes given these exposures (Pate et al., 1995).  
In 2007, the American College of Sports Medicine and the American Heart Association 
issued an updated recommendation for weekly exercise that included either five days per 
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week of moderate exercise lasting 30 minutes or longer, or three days per week of 
vigorous intensity exercise lasting 20 minutes or longer, or a combination of moderate 
and vigorous exercise. These updates were made in an effort to clear up confusion as to 
how much of each, moderate and vigorous, activity was necessary for improved health 
(Haskell, Lee, Pate, Powell, & Blair, 2007). 
The current physical activity recommendations from the US department of Health and 
Human Services are for 150 minutes of moderate intensity, or 75 minutes of high 
intensity physical activity per week (Physical Activity Guidelines Advisory Committee, 
2008). Since this recommendation was made the American Heart Association, American 
College of Sports Medicine, American Diabetes Association and American Cancer 
Society have made updates to their recommendations to comply (American Heart 
Association, 2014; Colberg et al., 2016; Garber et al., 2011; Kushi et al., 2012). Recent 
evidence from the Prospective Urban Rural Epidemiology study suggests that failure to 
achieve these minimum weekly recommendations is associated with a 20-35% greater 
risk of all-cause mortality (Lear et al., 2017).  
 
Estimates of Compliance 
It is estimated that 56.5-90.4% of adult Americans do not meet the minimum weekly 
physical activity recommendations of 150 minutes of moderate, or 75 minutes of 
vigorous, physical activity per week (Troiano et al., 2008; Tucker et al., 2011). This wide 
range of estimates can be attributed to differences in methodological approaches (Troiano 
et al., 2008; Tucker et al., 2011). Tucker et al. (2011) found a discrepancy between self-
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reported data and data collected via 7-day continuous accelerometry. In this report, 
62.0% of Americans met the weekly physical activity recommendations when asked to 
self-report, whereas only 9.6% of Americans met the recommendations according to 
accelerometry data. In an earlier report, Troiano et al. (2008) found similar discrepancies 
between self-report and accelerometry methods, and suggested that great care must be 
taken when interpreting self-reported physical activity data. However, the authors also 
suggested that the two methods give similar results regarding patterns of activity across 
gender and age groups. More recent accounts, based on self-reported data, suggest a 
pattern of increased physical activity amongst U.S. adults between 2008-2015. 
Specifically, the proportion of U.S. adults meeting weekly physical activity 
recommendations has increased from 43.5% in 2008, to 49.8% in 2015, with a peak level 
of 50% in 2012 (US Department of Health and Human Services, 2014). Regardless of 
methodology, these data suggest that much work needs to be done to increase population 
levels of physical activity. 
 
Diseases Related to Physical Inactivity 
There is currently an epidemic of diseases related to physical inactivity (Alzheimer’s 
Association, 2015; Center for Behavioral Health Statistics and Quality, 2016; Mariotto, 
Yabroff, Shao, Feuer, & Brown, 2011; Mozaffarian et al., 2016b), with most studies 
indicating that the primary diseases related to a lack of adequate physical activity include 
cardiovascular disease (CVD), stroke, type II diabetes mellitus (T2DM), Alzheimer’s 
disease (AD), depression, and breast and colon cancers. In the United States these 
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diseases have high prevalence rates, are associated with high direct medical costs, are all 
currently ranked on the top ten list of causes of death in the United States, and have all 
been shown to be modifiable through physical activity intervention. Table 1 details this 
information and sources. 
For these reasons, CVD, stroke, T2DM, AD, depression and breast and colon cancer were 
selected as a topic of further study within this dissertation. This group of diseases will be 
referred to as “the studied diseases” throughout this dissertation. 
 
Physiological Adaptations to Aerobic Physical Activity 
To better understand how physical activity intervention affects the relative risk of the 
studied diseases, it is important to have a good understanding of normal physiological 
adaptation to physical activity in healthy populations. The current recommendations for 
physical activity emphasize the use of aerobic methods and, not coincidentally, an 
overwhelming majority of the literature dedicated to the study of the effects of physical 
activity on disease have investigated aerobic methods of physical activity. For this 
reason, the focus of the, physiological adaptations to aerobic physical activity section and 
the mechanisms by which physical activity treats and prevents the studied diseases 
section, will be on aerobic physical activity. 
The chief limiting factor related to aerobic physical activity performance is the supply of 
oxygen to working musculature. Many of the adaptations that occur as a result of 
participation in regular aerobic physical activity improve the rate at which oxygen is 
delivered to working muscle tissue. Maximal oxygen uptake (VO2 max), is considered 
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the gold standard in the assessment of the overall function and capacity of the aerobic 
system (Jones & Carter, 2000; Lavie et al., 2015; Rivera-brown & Frontera, 2012).  
Oxygen consumption can be described by the Fick Equation: 
VO2=Q x (CaO2 - CVO2) 
Where VO2 refers to oxygen consumption, Q refers to cardiac output, and CaO2 - CVO2 
refers to the difference in oxygen saturation between arterial (Ca) and venous (CV) blood 
supply, commonly known as the arteriovenous oxygen difference (Rivera-brown & 
Frontera, 2012). Based on this equation it is possible to infer that oxygen consumption is 
primarily limited by the cardiovascular system, responsible for cardiac output, and the 
ability of working muscle to extract oxygen from the blood supply, quantified by the 
arteriovenous difference.  
 
The Pulmonary System  
Pulmonary Function can be described by the following equation: 
Minute Ventilation = Respiratory Rate X Tidal Volume 
Where minute ventilation is a measure of the volume of gas that enters and exits the lungs 
per minute, respiratory rate is the number of breaths per minute and tidal volume is the 
volume of air displaced per breath. During an acute aerobic physical activity bout, minute 
volume increases in a linear fashion relative to workload. Increases in tidal volume 
accomplish this response until ~65% of VO2 max is reached, at which point, increases in 
respiratory rate are required to increase minute volume (Dempsey, 1985). Similarly, total 
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pulmonary capillary blood volume increases with acute increases in workload and can 
reach levels three times that of resting values (Dempsey, 1985).  
The main function of the pulmonary system during aerobic physical activity is to 
oxygenate pulmonary blood flow while extracting carbon dioxide, this occurs by way of 
diffusion at the alveoli-capillary interface. This process results in arterial oxygen 
saturation which informs the CaO2 portion of the Fick equation. With the exception of 
elite level endurance athletes, or diseased individuals,  arterial oxygen saturation is rarely 
reduced in response to aerobic physical activity and therefore, is not a limiting factor in 
aerobic physical activity performance (Mckenzie, 2012). In fact, the pulmonary system 
has been described as “overbuilt” for aerobic performance (Mckenzie, 2012) and, unlike 
the cardiovascular system, the pulmonary system is relatively non-adaptive to aerobic 
physical activity (Dempsey, 1985; Dempsey & Wagner, 1999; Mckenzie, 2012). This 
inflexibility may be a result of the acute ability of the pulmonary system to respond to the 
demands of physical activity, as minute ventilation has the capacity to increase 20-fold 
compared to resting levels (Mckenzie, 2012) and arterial oxygen saturation is only 
affected by physical activity of extreme intensity, within only the highest trained 
populations (Dempsey, 1985; Dempsey & Wagner, 1999; Powers et al., 1988; Richards, 
Mckenzie, Warburton, Road, & Sheel, 2004). There is limited evidence that aerobic 
physical activity improves the strength and endurance capabilities of respiratory muscles 
in healthy human populations, however these capabilities are not thought to be limiting to 
aerobic performance and improvements are miniscule in comparison to adaptations made 
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by normal skeletal muscle in response to aerobic physical activity (Dempsey, 1985; 
Mckenzie, 2012). 
The pulmonary system appears to be relatively non-adaptive to aerobic physical activity 
as it is rarely a limiting factor in aerobic performance. 
 
The Cardiovascular System  
The cardiovascular system can be described by the following equation: 
Q= Stroke Volume X Heart Rate 
Where Q refers to cardiac output, stroke volume refers to the volume of blood pumped 
from the left ventricle per beat and heart rate is the number of times the heart beats per 
minute. During an acute bout of physical activity, cardiac output increases linearly with 
physical activity intensity from resting levels of ~5 L/min to exercising levels of, between 
20 and 40 L/min; depending on the level of conditioning of the individual (Arena, Myers, 
& Guazzi, 2008; Rivera-brown & Frontera, 2012). Increases in cardiac output in response 
to physical activity are due to increases in stroke volume, until physical activity 
intensities of 40-60% of VO2 max are reached, after which, Q is mediated by changes in 
heart rate (Gledhill, Cox, & Jamnik, 1994). Stroke volume at rest is typically ~50ml and 
can increase, based on the training status of the individual and intensity of physical 
activity to ~120 ml (Lavie et al., 2015; Rivera-brown & Frontera, 2012).  
A primary short-term adaptation to aerobic physical activity is increased stroke volume, 
resulting from an increase in left ventricle muscle mass, dilation  and contractility, 
collectively referred to as training induced cardiac remodeling (Baggish et al., 2008; 
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Lavie et al., 2015; Stuewe, Gwirtz, Agarwal, & Mallet, 2000). Increases in the volume 
and contractility of the left ventricle improve both the stroke volume and ejection 
fraction, the percentage of the blood volume in the left ventricle that is ejected each beat, 
resulting in a greater volume of blood flow per beat of the heart (Rivera-brown & 
Frontera, 2012). The increase in stroke volume leads to lower heart rates, both at rest, and 
at a given submaximal workload (Stuewe et al., 2000). 
Another short-term adaptation to aerobic physical activity is a reduction in blood 
pressure. Currently there is debate as to whether or not post-exercise hypotension 
(Kenney & Seals, 1993) is an acute adaptation to physical activity or a short-term 
adaptation (Cornelissen, Buys, & Smart, 2013; Cornelissen & Fagard, 2005; Kelley, 
Kelley, & Tran, 2001; Thompson et al., 2001), as it has been observed in response to as 
little as one exposure to aerobic physical activity (Jennings et al., 1991; Meredith, 
Jennings, & Esler, 1990; Pescatello et al., 1999) and returns to baseline levels between 16 
hours and 2 weeks post-exercise (Kenney & Seals, 1993; Meredith et al., 1990).  Larger 
changes in post-exercise hypotension have been observed in hypertensive compared to 
normotensive populations (Cornelissen et al., 2013; Cornelissen & Fagard, 2005; Fagard 
& Cornelissen, 2007; Hagberg & Brown, 1995; Kenney & Seals, 1993). Specifically, a 
meta-analysis performed by Cornelissen & Fagard (2005) demonstrated a reduction of 
2.4/1.6mmhg (SBP/DBP) in normotensive compared to a reduction of 6.9/4.9mmhg in 
hypertensive populations in response to chronic aerobic physical activity training 
interventions.  
   13 
 
Along with changes in blood volume, aerobic physical activity leads to improved 
production of nitric oxide and endothelium-dependent vasodilation (Dawson, Green, 
Cable, & Thijssen, 1985; Goto et al., 2003; Maiorana, O’Driscoll, Taylor, & Green, 
2003). Reduced viscosity, improved endothelium-dependent vasodilation and decreases 
in arterial stiffness lead to reductions in peripheral resistance, a mechanism of action for 
reduction in blood pressure (Paterson, Shephard, Cunningham, Jones, & Andrew, 1979; 
Shephard, 1992). 
The cardiovascular system responds to aerobic physical activity primarily through 
training induced cardiac remodeling, resulting in a larger capacity to pump blood 
throughout the body. Secondarily, reductions in peripheral resistance and increases in 
blood volume result in reduced blood pressure, increased oxygen carrying capacity and 
more efficient delivery of oxygen to working musculature. These adaptations to aerobic 
physical activity occur in the short-term, as all of the adaptations discussed above begin 
shortly after the onset of a training program. However, prolonged training is necessary 
for the maintenance of such adaptations and leads to greater stability of achieved 
adaptations (Issurin, 2010). Long-term and stable adaptations related to aerobic physical 
activity by the cardiovascular system are imperative to the improvement and maintenance 
of overall health.  
 
The Musculoskeletal System 
Though improvements in aerobic physical activity performance are largely attributed to 
adaptations made at the cardiovascular level, significant adaptations are made in response 
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to aerobic physical activity at the musculoskeletal level. Chief among these adaptations, 
are those related to improvements in oxygen diffusion rates, substrate uptake and storage, 
and oxidative metabolism. 
 Aerobic physical activity results in vascular remodeling at the myo-capillary level, 
referred to as angiogenesis (Risan, 1997), resulting in an increase in the number and 
density (per volume unit of muscle) of capillaries (Andersen & Henriksson, 1977; 
Holloszy, 2008; Ingjer, 1979; Laughlin & Roseguini, 2008; Rivera-brown & Frontera, 
2012; Swift, Johannsen, Lavie, Earnest, & Church, 2017). This increase in capillarity 
improves the maximal muscle blood flow capacity (Jones & Carter, 2000), which can 
increase more than 30-fold compared to resting levels during maximal aerobic physical 
activity (Andersen & Saltin, 1985; Gibala et al., 1998). Increased capillarity also 
increases surface area, and mean local transit time, allowing for improved diffusion of 
oxygen and uptake of necessary substrates (Jones & Carter, 2000).  
Along with increased muscular capillarization, the number and size of mitochondria, as 
well as the amount of oxidative and mitochondrial enzymes, are significantly elevated in 
response to aerobic physical activity; resulting in an increase in mitochondrial density 
and improved oxidative capacity of the affected muscle fibers (Egan & Zierath, 2012; 
Holloszy & Coyle, 1984; Howald, Hoppeler, Claassen, Mathieu, & Straub, 1985; 
Schantz, Sjoberg, & Svedenhag, 1986; Spina, Chi, & Hopkins, 1996; Suter, Hoppeler, & 
Claassen, 1995). This increase in mitochondrial density, particularly in the sub-
sarcollemal region of the muscle fiber, reduces the diffusion distance of oxygen, leading 
to an increased rate of oxidative metabolism (Rivera-brown & Frontera, 2012). Increases 
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in mitochondrial density have been observed after as few as eight to twelve weeks of 
training whereas increases in mitochondrial enzymatic activity, including citrate 
synthase, beta-hydroxyacyl-CoA dehydrogenase, mitochondrial thiolase, and carnitine 
acetyltransferase, were increased by 30% after only 7-10 days of training (Henriksson & 
Reitman, 1977; Klausen, Andersen, & Pelle, 1981; Spina et al., 1996). Reversal of the 
increase in mitochondrial density with the cessation of training was swift, occurring 
within six to eight weeks (Henriksson & Reitman, 1977; Klausen et al., 1981). However, 
individuals with longer training backgrounds (i.e. multiple years) appear to have 
developed more stable and long lasting adaptations (Holloszy & Coyle, 1984). 
Mitochondria are the primary site in which oxidative metabolism occurs. An increase in 
mitochondrial density of the muscle cell is accompanied by concomitant increases in 
myoglobin, which is responsible for oxygen delivery within the cell,  and malate-
aspartate shuttles, which are responsible for transporting NADH across the mitochondrial 
inner membrane; importantly, NADH is a rate limiting enzyme of the krebs cycle and 
electron transport chain (Egan & Zierath, 2012; Harms & Hickson, 1983; Holloszy & 
Coyle, 1984; Schantz et al., 1986; Spina et al., 1996; Suter et al., 1995) . These 
adaptations are logical as an increased rate of oxidative metabolism during physical 
activity, facilitated by increased mitochondrial density, relies upon the increased 
availability of cellular stores of oxygen and increases the demand for NADH. 
The respiratory exchange ratio (RER), a measure useful in the determination of the 
relative levels of β-oxidation and aerobic glycolysis, can be described by the following 
equation: 
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RER = VCO2/VO2 
Where VCO2 is the volume of carbon dioxide exhaled and VO2 is the volume of oxygen 
inhaled. Aerobic training leads to a decrease in (RER) (Holloszy, 1973). Where a 
decrease in RER implies increased reliance upon β-oxidation relative to aerobic 
glycolysis, due to increases in muscle triglyceride stores and oxidative enzymes related to 
lipolysis and β-oxidation (Coggan, Kohrt, & Spina, 1990; Green, Jones, & Ball-Burnett, 
1995; Green, Smith, & Murphy, 1990; Hurley, Nemeth, & Martin, 1986; Kiens & Essen-
Gustavsson, B Christensen, 1993; Martin, Dalsky, & Hurley, 1993). These adaptations 
facilitate glycogen sparing, important in aerobic performance, as glycogen depletion has 
been associated with fatigue (Wagenmakers et al., 1991). 
Relative to the musculoskeletal adaptations covered thus far, changes in muscle fiber type 
and size, tendon stiffness and bone density are long-term adaptations to chronic aerobic 
physical activity.  It has been observed that aerobic physical activity preferentially 
increases the cross-sectional area of type-I muscle fibers through physical activity 
induced hypertrophy and causes a shift in fiber type from type IIx to type IIa, as well as 
type IIa to type I, but not from type IIx to type I (Andersen & Henriksson, 1977; Sale, 
MacDougall, & Jacobs, 1990; Simoneau, Lortie, & Boulay, 1985; Spina et al., 1996). In 
comparison to untrained populations, well trained endurance athletes have been shown to 
possess increased tendon strength of 20% (Kubo, Kanehisa, Kawakami, & Fukunaga, 
2000). Similar cross sectional reports and research on animal species support the 
hypothesis that increased tendon strength is a long-term adaptation related to aerobic 
physical activity (Buchanan & Marsh, 2002; Kubo et al., 2000). Aerobic physical activity 
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involving bone loading (i.e. running and walking) has been shown to have limited 
positive effects on bone density, with higher impact physical activities, including 
jumping and resistance training, recommended as the most effective means to improve 
bone density (Guadalupe-Grau, Fuentes, Guerra, & Calbet, 2009). 
Short-term musculoskeletal adaptations to aerobic physical activity include increased 
capillary and mitochondrial density, increased reliance upon β-oxidation relative to 
aerobic glycolysis, and increases in proteins and enzymes related to the transport and 
metabolism of oxygen, NADH and triglycerides; including myoglobin and malate-
aspartate shuttles. Long-term musculoskeletal adaptations include hypertrophy of type-I 
muscle fibers along with shifts in fiber type expression in the direction of type-I fibers. 
These adaptations reduce the demands placed on the cardiovascular system and lead to 
better overall health. 
 
The Endocrine System  
Increased vascular shear stress and hypoxic myocellular conditions, caused by aerobic 
physical activity, lead to upregulation of vascular endothelial growth factor (VEGF) and 
endothelial nitric oxide synthase (eNOS), the primary regulator of nitric oxide (NO). 
VEGF and NO stimulate the production of endothelial progenitor cells (EPC’s) that act 
on multiple pathways and facilitate improved angio- and arteriogenesis, vascular repair, 
reduced hypothalamic-pituitary-adrenal (HPA) axis action, increased production of 
antioxidants and improved neuro and synaptogenesis (Carmeliet, 2000; Lenk, Uhlemann, 
Schuler, & Adams, 2011; Stranahan, Lee, & Mattson, 2008; Shoshanna Vaynman, Ying, 
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& Gomez-pinilla, 2004). These adaptations are important to the treatment and prevention 
of multiple disease states, including cardiovascular disease, stroke, Alzheimer’s disease, 
breast and colon cancer, and depression (Boer, Wörner, Verlaan, & Leeuwen, 2017; 
Lautenschlager, Cox, & Cyarto, 2012; Anne McTiernan, 2008; Schuler, Adams, & Goto, 
2013; Wegner, Helmich, Machado, Nardi, & Arias-carrión, 2014) 
Changes in myocellular ATP and Ca+ caused by aerobic physical activity, result in the 
activation of the AMP-Activated Protein Kinase (AMPK) and the Ca2+/Calmodulin-
Dependent Protein Kinases (CaMKs) pathways, responsible for insulin independent 
translocation of the glucose transporter protein GLUT4. Increased translocation and 
levels of GLUT4 associated with aerobic physical activity are vital adaptations in the 
treatment of type II diabetes (Cheng & Kujala, 2012; Stanford & Goodyear, 2014). 
Chronic aerobic physical activity is also associated with decreased resting levels of 
leptin, the catecholamines adrenaline and noradrenaline, cortisol, insulin and thyroid 
hormones (McMurray & Hackney, 2005; Zouhal, Jacob, Delamarche, & Gratas-
Delamarche, 2008). 
The endocrine response to aerobic physical activity is not fully understood, but it appears 
to be a primary system through which physical activity impacts disease states through 
improvement in endothelial and vascular function, regulation of insulin independent 
translocation of GLUT4 and maintenance of resting levels of a myriad of hormones. 
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Summary 
The breadth of adaptations that occur at every level of the body, in response to physical 
activity, underpins the potential power of physical activity itself. In the next section, the 
mechanisms by which physical activity acts to treat the studied diseases will reinforce the 
concept, that physical activity has unprecedented capability and scope as a prescription, 
related to disease prevention and treatment. 
 
Mechanisms by Which Physical Activity Treats and Prevents the 
Studied Diseases  
Cardiovascular Disease and Stroke 
The primary mechanism responsible for the prevention and treatment of CVD and stroke, 
related to physical activity intervention, appears to be the maintenance and restoration of 
endothelial function (Bowles & Laughlin, 2011; Lenk et al., 2011; Schuler et al., 2013). 
A promising mechanism for the treatment of those already suffering from various forms 
of CVD is the amplification of coronary collateral growth through physical activity 
intervention (Bowles & Laughlin, 2011; Heaps & Parker, 2011; Schuler et al., 2013; 
Seiler, 2003). 
 
Endothelial Dysfunction 
Endothelial dysfunction has been identified as a major contributor to CVD and stroke. 
Endothelial progenitor cells (EPC’s) play an important, though not fully understood, role 
in endothelial function (Lenk et al., 2011). It is thought that EPC’s reparative action at the 
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endothelial wall level is related to either their ability to mature into endothelial cells 
themselves (Urbich & Dimmeler, 2004), or to signal for the secretion of growth 
differentiation factors, which in turn, stimulate mature endothelial cells to differentiate 
(Lenk et al., 2011). Circulating levels of EPC’s appear to be regulated by NO 
concentrations which have been shown to be stimulated through aerobic physical activity 
in two ways (Adams et al., 2004; Laufs et al., 2004; Steiner et al., 2005). First, 
endothelial shear stress, associated with increased cardiac output, upregulates endothelial 
nitric oxide synthase (eNOS) (Fisslthaler, Dimmeler, Hermann, Busse, & Fleming, 2000; 
Newcomer, Thijssen, & Green, 2011), leading to increased levels of NO which, in turn, 
stimulate matrix metalloproteinase-9 (MMP-9) in bone marrow leading to the 
mobilization of EPC’s (Iwakura et al., 2006). Second, hypoxia of the muscle cell during 
physical activity leads to increased levels of hypoxia-inducible factor-1 (HIF-1) which 
leads to increased production of vascular endothelial growth factor (VEGF), stromal cell-
derived factor-1 (SDF-1), and erythropoietin (EPO) (Asahara, Takahashi, & Masuda, 
1999; Heeschen et al., 2003). In the same manner as NO, these three molecules stimulate 
the mobilization of EPC’s via MMP-9 in the bone marrow. Aerobic physical activity has 
also been shown to stimulate the chemokine receptor type 4 (CXCR4) and the very late 
antigen-4 VLA4 receptors, responsible for the “homing” of EPC’s to damaged sites along 
the endothelium (Askari et al., 2003; Lenk et al., 2011).   
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Coronary Collateral Growth 
Atherosclerosis, the hardening and narrowing of blood vessels, especially the arteries, is 
one of the most common underlying causes of CVD (Mozaffarian et al., 2016a). In 
response to atherosclerotic conditions, including ischemic conditions and vascular shear 
force, the vasculature system may develop alternative arterial and capillary pathways, via 
arteriogenesis and angiogenesis, in an effort to supply oxygen to the heart (Heil, 
Eitenmuller, Schmitz-Rixen, & Schaper, 2006; Risan, 1997). This process, termed 
coronary collateral growth, has been shown to reduce the magnitude of infarct and lead to 
improved chances of survival (Heaps & Parker, 2011). Newly formed arteries are referred 
to as “natural bypasses” and are viewed as possible alternatives to invasive bypass 
surgeries and angioplasty (Heil et al., 2006; Seiler, 2003). Though the exact underlying 
mechanisms of angiogenesis and arteriogenesis are not fully understood, it appears that 
many of the key molecules involved in healthy endothelial function play important roles, 
including eNOS, VEGF, HIF-1, SDF-1, CXCR4 and EPC’s (Carmeliet, 2000; Heil et al., 
2006; Schuler et al., 2013; Seiler, 2003). The role of these molecules along with the role 
of shear stress as a mediating factor in arteriogenesis have led researchers to hypothesize 
that physical activity may serve as a stimulating intervention, due to the fact that exercise 
is known to stimulate these pathways (Carmeliet, 2000; Heil et al., 2006; Schuler et al., 
2013; Seiler, 2003).  There is strong evidence to support this theory in animal models, 
however results of human interventions are less clear (Heaps & Parker, 2011; Seiler, 
2003). Researchers have theorized that the current assessment techniques available for 
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use in human trials are not sensitive enough to capture collateral growth, a problem not 
faced in animal trials (Heil et al., 2006; Seiler, 2003).  
 
Type II Diabetes Mellitus 
There are multiple mechanisms by which physical activity improves symptoms of T2DM, 
the most crucial of which appears to be the improved translocation, and abundance of, 
glucose transporter proteins. Other mechanisms include maintenance, and increases in, 
muscle mass, reductions in visceral fat deposits, improvements in mitochondrial function, 
and improvements in musculoskeletal glycogen synthesis. 
 
Translocation and Abundance of Glucose Transporter Proteins  
Type II Diabetes Mellitus, is the result of the development of insulin resistance at the 
muscle, liver and adipose tissue levels (DeFronzo & Tripathy, 2009; Stanford & 
Goodyear, 2014). Resistance to insulin leads to the inability of these sites to uptake 
glucose from the blood, this inability primarily stems from the inability of insulin to 
stimulate the translocation of glucose transporter proteins, specifically GLUT4 (Burr, 
Rowan, Jamnik, & Riddell, 2010; Cheng & Kujala, 2012; Stanford & Goodyear, 2014; 
Strasser & Pesta, 2013). It has been demonstrated that acute and chronic physical activity 
bouts, both aerobic and resistance training based, increase blood glucose uptake through 
increased abundance and translocation of GLUT4, via pathways alternative to the insulin 
dependent pathway (Gaster, Vach, Beck-Nielsen, & Schroder, 2002; Higashida, Kim, 
Higuchi, Holloszy, & Han, 2011; Holten et al., 2004; Richter & Hargreaves, 2013).  It 
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appears that changes in cellular AMP, ATP and Ca2+ caused by muscular contraction 
during physical activity, result in multiple signaling cascades that result in the 
translocation of GLUT4 (Richter & Hargreaves, 2013; Rockl, Witczak, & Goodyear, 
2008; Stanford & Goodyear, 2014). These pathways are not fully understood, however, 
Stanford & Goodyear (2014) referred to the AMP-Activated Protein Kinase (AMPK) and 
the Ca2+/Calmodulin-Dependent Protein Kinases (CaMKs) as the most studied and 
influential pathways. It is recognized that insulin dependent, AMPK and CaMKs share 
common downstream targets; the molecules AS160 and TBC1D1, both of which play an 
integral role in the translocation of GLUT4 (Stanford & Goodyear, 2014). This common 
pathway may be a key factor in the long term positive effects of physical activity on 
insulin sensitivity.  
 
Other Mechanisms 
Skeletal muscle typically constitutes more than one third of total body mass  and is the 
largest site of blood glucose uptake in the body (Strasser & Pesta, 2013). Increases in 
muscle mass, through resistance training, are proposed to increase the potential for blood 
glucose uptake and reverse the age-related effects of sarcopenia (Gaster et al., 2002). It 
has been observed that type I muscle fibers have greater insulin sensitivity and are 
typically expressed in lower relative amounts in diabetic populations (Albright, Franz, & 
Hornsby, 2000; Corcoran, Lamon-Fava, & Fielding, 2007). Fiber type shifts, towards 
type I (those that are more oxidative in nature) as a result of aerobic training, are 
considered beneficial adaptations. 
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Increased visceral fat deposits are associated with increased risk of T2DM (Bjorntop, 
1991; Coggan et al., 1990; Ivy, 1997), possibly due to the suppressant effect of tumor 
necrosis factor-α (TNF-α), a hormone like substance produced in adipose tissue, on 
GLUT4 translocation (Stephens & Pekala, 1991). Aerobic and resistance training have 
been shown to reduce visceral fatty deposits, preferentially (Despres, Nadeau, & 
Bouchard, 1988). 
Populations suffering from T2DM have been shown to have reduced function and 
abundance of mitochondria, which has been linked to insulin resistance (Patti et al., 
2003). Aerobic physical activity has been shown to completely reverse these deficits 
(Meex et al., 2010). 
Once blood glucose is transported into the cell it is either metabolized or converted to 
glycogen via the enzyme glycogen synthase. Populations with T2DM have been observed 
to have low levels of glycogen synthase (Shulman et al., 1990), these levels can be 
improved through aerobic and resistance training interventions (Cauza, Hanusch-Enserer, 
& Strasser, 2005; Ferrara, Goldberg, Ortmeyer, & Ryan, 2006; Hughes, Fiatarone, & 
Fielding, 1993). Based on this abundant evidence, it is likely that physical activity 
reduces T2DM primarily through increased translocation and abundance of GLUT4, as 
well as through peripheral muscular adaptations including increased mitochondrial 
function, density and number. 
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Alzheimer’s Disease 
The primary mechanisms by which physical activity is believed to prevent and slow the 
rate of decline in AD appear to be related to improvements in cerebral blood flow, 
reduction in oxidative stress and improvements in neuronal plasticity (Chen, Zhang, & 
Huang, 2016; Lange-asschenfeldt & Kojda, 2008; Radak et al., 2010).  
 
Cerebral Blood Flow 
AD is associated with reduced cerebral blood flow, caused in part by limited functional 
angiogenesis and arteriogenesis, characteristics of overall impaired endothelial function, 
similar to that of CVD (Torre, 2002). Due to these similarities, the role that physical 
activity plays in the treatment and prevention of AD is comparable to its role in the 
treatment and prevention of CVD. Specifically, increases in vascular shear stress and 
hypoxic conditions, induced by physical activity, lead to increased production of eNOS 
and HIF-1 which lead to increased production of NO and VEGF, respectively. NO and 
VEGF stimulate MMP-9 in bone marrow, which causes an increase in circulating EPC’s. 
These EPC’s are responsible for a myriad of endothelial functions related to vascular 
plasticity, including endothelial repair and an increase in functional capacity for angio- 
and arteriogenesis (Lenk et al., 2011). Increases in the rate of angiogenesis lead to 
increased cerebral capillarization and cerebral blood flow, adaptations thought to play a 
major role in the prevention and treatment of symptoms of AD (Lange-asschenfeldt & 
Kojda, 2008). 
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Reduction of Oxidative Stress 
AD is characterized by cerebral amyloid angiopathy (CAA), or high levels of 
extracellular senile plaque, comprised primarily of amyloid-β (Aβ) as well as the buildup 
of intracellular neurofibrillary tangles, comprised of the protein tau (Dubois et al., 2010). 
Aβ accumulation reduces cerebral blood flow through its physical presence within 
cerebral vasculature and inhibits the activity of eNOS (Suhara et al., 2003). Measured 
accumulation of these proteins is a diagnostic characteristic of AD (Ahlskog, Geda, 
Graff-radford, & Petersen, 2011). Aβ and tau are also associated with increased 
production and accumulation of reactive oxygen species (ROS) which in turn lead to high 
levels of oxidative stress, causing neurodegeneration and increased CAA, creating a 
damaging cycle of increased Aβ production (Zhao & Zhao, 2013).  
Moderate and high intensity aerobic physical activity have been shown to both reduce the 
production capacity for ROS and increase the production of antioxidants including eNOS, 
brain-derived neurotrophic factor (BDNF), and VEGF. These positive adaptations to 
physical activity have been observed to lead to reductions in the concentration of Aβ 
plaques, neurofibrillary tangles of tau and overall markers of oxidative stress (Chen et al., 
2016; Lange-asschenfeldt & Kojda, 2008; Radak et al., 2010; Shoshanna Vaynman et al., 
2004).  
 
Neuronal Plasticity 
Neuronal plasticity refers to the ability of the brain to make new neurons and synapses 
through the processes of neurogenesis and synaptogenesis, respectively. These processes 
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are integral to the regulation of learning and the formation of long-term memory. Patients 
suffering from AD have decreased capacity for both processes (Shoshanna Vaynman et 
al., 2004). 
An important neurotrophin that mediates neurogenesis and synaptogenesis is BDNF 
(Shoshanna Vaynman et al., 2004). It has been observed, in experimental trials, that 
BDNF gene deletion or inhibition leads to decreases in long term potentiation, the 
process by which learning and memory formation take place (Figurov, Pozzo-Miller, 
Olafsson, Wang, & Lu, 1996; Kang, Welcher, Shelton, & Schuman, 1997). Further, these 
deleterious effects can be reversed with the application of external sources of BDNF or 
overexpression of the gene (Korte et al., 1995; Patterson et al., 1996). The mechanism(s) 
by which BDNF regulates neurogenesis, synaptogenesis, memory and learning are not 
fully understood, however, it has been observed that BDNF regulates the production of 
cAMP response-element-binding (CREB) protein, a transcriptional factor that plays an 
integral role in the formation and survival of neurons, and synapsin I (SYN-I), a 
phosphoprotein integral in the formation and survival of synapses (Gomez-Pinilla, So, & 
Kesslak, 2001; S. Vaynman, Ying, & Gomez-Pinilla, 2003). 
Cellular hypoxia, caused by physical activity, leads to the production of HIF-1, which in 
turn stimulates the production of the circulating factors VEGF, SDF-1 and EPO (Lenk et 
al., 2011). Although this same cascade is important to endothelial function in both CVD 
and AD due to the downstream production of EPC’s and the corresponding increase in 
arterio- and angiogenesis, special attention has been paid to VEGF as a primary regulator 
of brain-derived neurotrophic factor (BDNF) (Vaynman & Gomez-Pinilla, 2006). It has 
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been demonstrated that circulating BDNF and amount of physical activity performed are 
positively correlated and that these increased levels of circulating BDNF, post- physical 
activity, have been positively correlated with levels of CREB and SYN-I (Shoshanna 
Vaynman et al., 2004). CREB and SYN-I are responsible for stimulating neuro- and 
synaptogenesis (Matta, Cevada, & Monteiro-junior, 2013).  
Physical activity is thought to reduce the risk of, and ameliorate the symptoms of AD, at 
least in part, through the stimulation of BDNF and the concomitant improvements in 
neuro- and synaptogenesis, the underpinning mechanisms for learning and long-term 
memory formation. 
 
Depression 
There are two main mechanisms by which physical activity is thought to effect 
depression; adaptation of the hypothalamic-pituitary-adrenal (HPA) axis and the 
neurotrophic hypothesis (Matta et al., 2013; Wegner et al., 2014). 
 
Hypothalamic-Pituitary-Adrenal Axis 
Depression is thought to be caused, in part, by dysfunctional control of cortisol levels 
through the HPA-axis. Stress leads to a release of corticotropin-releasing hormone (CRH) 
in the hypothalamus that stimulates the pituitary to release adrenocorticotropic hormone, 
which in turn, stimulates the adrenal gland to release cortisol, “the stress hormone”, 
which acts upon mineralocorticoid receptors (MR) throughout the body (Matta et al., 
2013). Too much cortisol-MR interaction in the brain can lead to neuronal injury 
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pathways supposed to cause depression (Yuan et al., 2015).  Although acute bouts of 
physical activity are known to stimulate this system and lead to the release of cortisol, 
chronic aerobic physical activity has been shown to reduce resting cortisol levels and the 
level of cortisol increase in response to stressful stimuli (Matta 105). The exact 
mechanism by which physical activity effects the HPA axis is unknown, however it is 
thought that physical activity may improve the density and sensitivity of MR and inhibit 
cortisol synthesis, leading to a net effect of improved cortisol sensitivity (Matta et al., 
2013). 
 
The Neurotrophic Hypothesis 
Depression is characterized by decreased hippocampal volume as a result of decreased 
neuro- and synaptogenesis (Wegner et al., 2014). The hippocampus is the center of 
learning, memory formation (discussed in the AD section) and mood state or emotion. 
physical activity increases hippocampal volume by increasing neuronal plasticity, neuro- 
and synaptogenesis in the same manner described in the AD section above (Matta et al., 
2013; Wegner et al., 2014). Muscular contraction and hypoxic conditions lead to 
increased production of neurotrophins, including BDNF and VEGF, which lead to 
increased production of CREB and SYN-I, that in turn, stimulate neuro- and 
synaptogenesis. These adaptations cause increased hippocampal volume leading to 
improved symptoms of depression (Rebar, Stanton, Geard, Short, & Duncan, 2015). 
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Breast and Colon Cancer 
The strongest evidence for a protective role played by physical activity against cancer is 
related to breast cancer. Relatively little is known about the mechanisms of action related 
specifically to colon cancer, as mush less research has been done in this area. It is early in 
the research process and the mechanisms studied are currently considered hypotheses, as 
enough evidence has not yet been gathered. Proposed mechanisms by which physical 
activity treats and prevents breast, colon and other cancers, include reduction in sex 
hormone levels, improvement of insulin sensitivity, altered adipocytokines, decreased 
inflammation and improved immune function (Boer et al., 2017; Graf & Wessely, 2010; 
Anne McTiernan, 2008).  
 
Reduction in Sex Hormones 
Free circulating estrogen is associated with increased risk for breast cancer (Key, 
Appleby, Barnes, & Reeves, 2002). Moderate intensity aerobic physical activity is 
associated with decreased production of estrogen, whereas reduction in adipose tissue, 
physical activity induced or not, results in the increased production of sex hormone-
binding globulin (SHBG) (A McTiernan et al., 2004),  a steroid binding glycoprotein that 
regulates the availability of free circulating estrogen (Gascon, Valle, & Martos, 2000). 
Combined, these adaptations lead to a net reduction in free circulating estrogen, 
especially in post-menopausal females, a possible protective effect of physical activity 
(M. F. Chan, 2007; Mctiernan, 2006; Verkasalo, Thomas, Appleby, Davey, & Key, 
2001). 
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Improvement of Insulin Sensitivity 
Insulin resistance has also been associated with increased risk of cancer. High levels of 
insulin due to reduced insulin sensitivity can result in tumor development directly, by 
reducing apoptosis and increasing cell proliferation, or indirectly, by reducing production 
of SHBG (Kaaks & Lukanova, 2001). The effect of physical activity on insulin resistance 
has been discussed in the T2DM section above.  
 
Altered Adipocytokines 
Leptin is a hormone produced in adipose tissue that regulates cell growth and 
proliferation  and has been observed to be overexpressed in breast tumors (Harris, 
Tworoger, Hankinson, Rosner, & Michels, 2011; Jarde, Caldefie-Chezet, & Goncalves-
Mendes, 2009). Adiponectin is an anti-inflammatory hormone, inversely related to fat 
mass, that acts to reduce proliferation of breast cancer cells, downregulate TNFα and 
serves as an indicator of insulin sensitivity (Grossmann, Ray, & Nkhata, 2010; Jarde et 
al., 2009; Tworoger, Eliassen, & Kelesidis, 2007). There is evidence to suggest that the 
ratio of leptin to adiponectin is an important factor in breast cancer prevention 
(Grossmann et al., 2010). Both aerobic and resistance training have been shown to lower 
leptin levels and raise adiponectin levels, creating a more favorable ratio (Bouassida et 
al., 2010; de Salles, Simao, Fleck, Dias, & Kraemer-Aguiar, LG Bouskela, 2010; Gleeson 
et al., 2011). These adaptations are achieved through three mechanisms; reduction in 
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adipose tissue, increases in anti-inflammatory cytokines due to muscular contraction, and 
reduction in Toll-like receptors on macrophages and monocytes (Gleeson et al., 2011).  
 
Decreased Inflammation 
C-reactive protein (CRP), interleukin 6 (IL-6) and TNFα are all inflammatory factors that 
have been associated with increased cancer risk (Il’yasova, 2005). Exercise has been 
shown to suppress the expression of TNFα and reduce the presence of inflammatory 
markers in the body (Petersen & Pedersen, 2005) . The exact mechanism by which these 
factors are downregulated is not known, however it has been shown that increased levels 
of adiponectin and decreased fat mass play an important role (Anne McTiernan, 2008). 
 
Improved Immune Function 
Natural killer (NK) and cytotoxic T cells (T-cells) are thought to play integral roles in the 
immune systems defensive role against cancer (Anne McTiernan, 2008). During aerobic 
physical activity catecholamine release leads to increases in NK cells and T-cells of 150-
300 and 50-100 percent respectively (Nieman, 1994). Upon the release of cortisol, shortly 
after physical activity, NK and T-Cell levels drop to levels below baseline, but there is 
evidence to suggest that they may be functioning at higher capacity, offsetting the drop 
below baseline (Nieman, 1994). There is not enough evidence at this point to draw any 
conclusions as to how physical activity affects the immune system and how those effects 
may relate to breast or colon cancer risk, however the hypothesis remains (Graf & 
Wessely, 2010; Anne McTiernan, 2008; Pedersen & Hoffman-Goetz, 2000). 
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Summary 
The mechanisms of action by which physical activity acts upon the studied disease states 
are widely variable. Physical activity is the initial stressor for many adaptive responses 
that aid the human body in warding off disease. This multi-variable protective effect 
cannot be oversold, as it has the potential to replace multiple pharmacological 
interventions, for multiple and concurrent disease states, in a single prescription. 
 
Physical Activity vs. Pharmacological Intervention 
Physical activity has been shown to be just as, if not more, effective than 
pharmacological intervention in treating the studied diseases (Alberti, Zimmet, & Shaw, 
2007; Aune et al., 2015; Blondell, Hammersley-mather, & Veerman, 2014; Cole et al., 
2009; Diep, Kwagyan, Kurantsin-Mills, Weir, & Jayam-Trouth, 2010; Diniz, Pinto, 
Guimares, Gattaz, & Forlenza, 2009; Freedman et al., 2011; Hamer & Chida, 2009; Jeon, 
Hu, Lokken, Dam, & M., 2007; Johnson et al., 2013; Kyu et al., 2016; Law, Morris, & 
Wald, 2009; Li, Loerbroks, & Angerer, 2013; Li & Siegrist, 2012; Naci & Ioannidis, 
2013; Robsahm et al., 2013; Sattelmair et al., 2011; Silveira et al., 2013; Francesco Sofi, 
Capalbo, Cesari, Abbate, & Franco, 2008; Wegner et al., 2014; Wolin, Yan, Colditz, & 
Lee, 2009; Wu et al., 2013). Table 2 provides a summary of the relative risk for each 
disease studied, given both physical activity and pharmacological intervention. Physical 
activity has the added advantage of working to treat all of the diseases related to physical 
inactivity at once, with minimal potential for drug interactions or adverse side effects. 
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This section will compare the protective effects of physical activity as a preventive 
measure to pseudo-preventative pharmacological interventions, for each of the studied 
diseases. The qualifier “pseudo-preventative” is used to underline the fact that there are 
no true preventative pharmacological interventions for any of the disease states in 
question. Instead prescription medications are used only in high risk populations, or with 
those already afflicted by disease, due to the potential for adverse side effects.  
 
Cardiovascular Disease and Stroke 
In the past decade, there have been four meta-analyses that have analyzed the role of 
physical activity in preventing heart disease (Li et al., 2013; Li & Siegrist, 2012; 
Sattelmair et al., 2011; Francesco Sofi et al., 2008). Similarly, there have been four meta-
analyses that have analyzed the role of physical activity in preventing stroke (Diep et al., 
2010; Kyu et al., 2016; Li et al., 2013; Li & Siegrist, 2012). These analyses share the 
same conclusion, moderate to high levels of physical activity reduce the risk of heart 
disease and stroke by 14-34% and 11-29% respectively. There is also evidence, though 
less definitive in the case of stroke, for a dose-response relationship between physical 
activity and its protective effects.  
In a meta-analysis of 154 RCT’s of blood pressure lowering drugs, including beta-
blockers, for the prevention of heart disease, it was found that the protective effect of 
blood pressure medication was directly due to reduction in blood pressure. The combined 
effect for all drug types was a reduction in risk of CVD by 15% and of stroke by 27% 
(Law et al., 2009). This study highlights the similar reduction in risk between physical 
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activity and pharmacological intervention. Reduction in risk was given for all 
medications combined, due to the fact that no drug showed favorable outcomes compared 
to another, a phenomenon that has been well documented (Blood Pressure Lowering 
Treatment Trialists’ Collaboration, 2003, 2008; Law et al., 2009).  
 
Type II Diabetes Mellitus  
In the past decade, two meta-analyses have been performed detailing the relative risk of 
developing T2DM with and without physical activity. 
A meta-analysis of 81 studies found that those in high physical activity groups, compared 
to low physical activity groups, were 35% (RR- 0.65, 95% CI 0.59–0.71) less likely to 
develop T2DM (Aune et al., 2015). The authors looked more specifically at different 
intensities and types of physical activity including leisure time activity, vigorous activity, 
moderate activity, light activity, resistance training and walking and reported that all 
investigated physical activity categories were associated with 25-40% reductions in risk 
of T2DM with the exceptions of walking, occupational activity and cardiorespiratory 
fitness associated with 15%, 15% and 55% reductions in risk, respectively. Aune et al. 
(2015) concluded that increased levels of physical activity, of any kind, are beneficial in 
reducing the risk of T2DM.  
Jeon, Hu, Lokken, Dam, & M. (2007) conducted a meta-analysis of 10 prospective cohort 
studies of the effects of moderate physical activity on T2DM outcomes and reported that 
regular participation in physical activity of moderate intensity was associated with a 31% 
(RR-0.69, 95% CI 0.58–0.83) lower risk of developing T2DM compared with being 
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physically inactive. The authors also found that participants that walked briskly for more 
than two and a half hours per week were 30% less likely, compared to those that took part 
in little to no walking, to develop T2DM (RR-0.70 95% CI 0.58–0.84).  
According to the most recent standards of medical care in diabetes from the American 
Diabetes Association, Metformin is the only recommended drug for use in the treatment 
of T2DM, based on strong evidence in terms of efficacy and long-term safety. Per the 
same report, Metformin is less effective overall than lifestyle intervention strategies, that 
include diet and physical activity interventions, and equally effective in populations with 
a BMI >35. This same report goes on to address the use of other drugs with the following 
statement, “For other drugs, cost, side effects, and lack of a persistent effect require 
consideration” (American Diabetes Association, 2014).  
In a summary of major diabetes intervention studies Alberti, Zimmet, & Shaw (2007) 
found that drug interventions involving Metformin, Troglitazone, Acarbose, Orlistat, and 
Rosiglitazone showed risk reductions ranging from 25-75% whereas lifestyle 
interventions showed risk reductions ranging from 28-67%. Similarly, in a systematic 
review and meta-analysis of pharmacological and lifestyle interventions, lifestyle 
interventions were found to be at least as effective as pharmacological interventions 
(Gillies et al., 2007). Supporting this sentiment, Naci & Loannidis, (2013) concluded that 
physical activity is equally as effective as drug intervention in terms of mortality caused 
by T2DM. Furthermore, Montori & Fernandez-Balsells (2009) concluded that there is not 
enough evidence to support the current widespread use of medications to treat T2DM.  
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Besides failing to be more effective than physical activity T2DM medications are 
associated with side effects that include gastrointestinal distress, decreased liver function, 
increased risk of congestive heart failure and increase risk of bone fracture (Gillies et al., 
2007; Lago, Singh, & Nesto, 2007; Loke, Singh, & Furberg, 2009; Nissen & Wolski, 
2007, 2010), and are only recommended for individuals at high risk (American Diabetes 
Association, 2014).  
 
Alzheimer’s Disease 
Over the past decade three meta-analyses have investigated the role of physical activity 
as a preventative factor for dementia, in previously non-demented populations (Blondell 
et al., 2014; Hamer & Chida, 2009; F Sofi et al., 2010). 
In a meta-analysis that included 47 cohorts, Blondell et al. (2014) found that participants 
with higher levels of activity, compared to those with lower levels of activity, were 35% 
less likely to develop cognitive decline (RR- 0.65, 95% CI 0.55-0.76), an early indicator 
of dementia, and 14% less likely to develop dementia (RR- 0.86, 95% CI 0.76-0.97), the 
disease category under which AD falls. 
Similarly, in a meta-analysis of 15 prospective studies, Sofi et al. (2010) found that 
participants in the high activity group compared to those in a physically inactive group 
were 38% less likely to develop cognitive decline (HR 0.62, 95% CI 0.54–0.70) and 
participants in a low-moderate activity group were 35% less likely to develop cognitive 
decline (HR 0.65, 95% CI 0.57–0.75). 
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Lastly, in a meta-analysis of 16 prospective studies, Hamer and Chida (2009) found that 
participants in the highest, compared to the lowest, activity level group had a 28% lower 
chance (RR- 0.72 95% CI 0.60–0.86) of developing dementia and a 45% lower chance 
(RR- 0.55 95% CI 0.36–0.84) of developing AD, specifically. 
In a more recent retrospective study, Tolppanen et al. (2015) found that physical activity 
during mid-life, decreased the relative risk of AD and dementia later in life. Furthermore, 
the maintenance of, or increase in activity, past the mid-life point also led to a reduction 
in risk of AD and dementia later in life. 
An important limitation to these conclusions is the lack of sufficient evidence to prove a 
causal relationship; that is to say, all three sets of authors discussed the possibility that 
dementia may in fact be the reason that participants do not participate in physical activity 
(Blondell et al., 2014; Hamer & Chida, 2009; F Sofi et al., 2010).  
There are no pharmacological interventions that have been used to effectively treat AD. 
Pharmacological interventions used to slow cognitive decline and other symptoms related 
to AD utilize cholinesterase inhibitors (CI’s). This group of medication is recommended 
only for use in populations with moderate to severe forms of AD (Vahabzadeh, Delaffon, 
& Abbas, 2010) due to side effects, including nausea, vomiting, diarrhea, dizziness, 
headache, weight loss, anorexia, muscle cramps, abdominal pain (Geldmacher, 2003) and 
a limited magnitude of effect (Vahabzadeh et al., 2010). In a meta-analysis of four RCT’s 
of CI’s used to prevent the progression of mild cognitive impairment to AD, CI’s were 
found to reduce the risk of further progression by 25% (RR- 0.75 95% CI 0.65-0.87) 
(Diniz et al., 2009).  
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Depression 
Research related to physical activity as a preventative strategy for depression is limited. 
Instead, researchers focus on physical activity as a means of treatment.  
In a meta-analysis of 10 longitudinal trials, Silveira et al. (2013) reported a 0.61 (95% CI: 
–0.88 to –0.33) standard deviation reduction in the intervention group compared to the 
control group. In the same analysis, it was reported that physical activity intervention 
groups were 49% (RR- 1.49; 95% CI 1.10–2.03) more likely to see improvements in 
symptoms of depression compared to controls. 
Currently, the area of research related to the efficacy of pharmacological intervention and 
physical activity intervention as treatments for depression is contentious. In a summary of 
seven meta-analysis regarding the efficacy of physical activity as a treatment, Josefsson, 
Lindwall, & Archer (2014) stated that “the main results from seven meta-analyses so far 
show that physical activity has an antidepressant effect compared with control conditions 
that ranges from slightly moderate (g = –0.40) to very large (g = –1.39). However, the 
majority of the included studies in all these meta-analyses suffer more or less from 
serious methodological problems (e.g., small samples, inadequate allocation 
concealment, lack of intention-to-treat analysis and blinding, and lack of clinical 
interviews to diagnose depression)”. 
Similarly, the efficacy of anti-depressant medication is under scrutiny as some 
researchers claim that drug-placebo differences are relatively small for depressed patients 
(Kirsch et al., 2008), whereas others claim that the drug effect is large and always present 
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(Fountoulakis & Moller, 2011). Interestingly both groups of researchers used the exact 
same data set when coming to these contradictory conclusions. 
In favor of physical activity and antidepressant use, Blumenthal et al. (2007), after 
conducting a prospective cohort trial, concluded that physical activity and drug 
interventions were equally effective, and both were more effective than placebo. 
 
Breast Cancer 
In the past decade, there has been one meta-analysis performed, specifically analyzing the 
role of physical activity in the prevention of breast cancer. Wu et al. (2013) analyzed 31 
prospective studies with 63,786 participants and reported that, overall, participation in 
physical activity reduces the risk of breast cancer by 12% (RR-0.88 95% CI- 0.85–0.91). 
The authors also reported a dose-response relationship between physical activity and risk 
of breast cancer, stating that the risk of breast cancer decreased by five percent for every 
two hour/week increase in moderate to vigorous physical activity. 
Tamoxifen and Raloxifene are the two pharmacological options recommended by the 
Breast Cancer and Environmental Research Coordinating Committee, to reduce the risk 
of breast cancer in high risk populations (Interagency Breast Cancer and Environmental 
Research Coordinating Committee, 2013). Though Tamoxifen has been shown to reduce 
breast cancer risk by 24% (RR-1.24, 95% CI 1.05–1.47) (Freedman et al., 2011) and 
Raloxifene has been shown to be 76% as effective as Tamoxifen (Freedman et al., 2011; 
Vogel et al., 2010), both are recommended for use only in high risk populations due to 
toxic side effects that include increased risk of endometrial cancer, stroke, pulmonary 
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embolism, deep vein thrombosis, and cataracts (Fisher et al., 1998; Freedman et al., 2011; 
Vogel et al., 2010). 
 
Colon Cancer 
Three meta-analyses have been performed analyzing the role of physical activity in the 
prevention of colorectal cancer (Johnson et al., 2013; Robsahm et al., 2013; Wolin et al., 
2009). In a meta-analysis of colorectal cancer by anatomical region, Robsahm et al. 
(2013) found a reduction in risk of proximal and distal colon cancer of 24% (RR 0.76, 
95% CI 0.70-0.83) and 23% (RR 0.77, 95% CI 0.71–0.83) respectively, but did not find a 
significant reduction in rectum cancer. Johnson et al. (2013) found an overall reduction in 
the risk of colorectal cancer of 12% (RR-0.88, 0.86–0.91). Subgroup analysis revealed a 
27% (RR- 0.73, 0.68–0.79) reduction in colon cancer, and a non-significant relationship 
for rectum cancers. Wolin et al. (2009) conducted a meta-analysis in which physical 
activity was found to reduce the risk of overall colorectal cancer by 24% (RR-0.76 95% 
CI- 0.72, 0.81).  Taken together, these studies lend evidence to the theory that physical 
activity may be effective in preventing colon, but not rectum cancer. 
Relatively high doses of aspirin and Cox-2 selective inhibitors are the current 
pharmacological interventions directed at preventing colorectal cancer (A. T. Chan & 
Giovannucci, 2010). Cole et al. (2009) performed a meta-analysis on the efficacy of large 
doses of aspirin and found that it reduced the risk of colorectal cancer by 17% (RR- 0.83 
95% CI, 0.72– 0.96). Several subsequent studies have confirmed this finding, with the 
exception being, studies that utilized smaller doses (A. T. Chan et al., 2006, 2008; Cook 
   42 
 
et al., 2005; Flossmann & Rothwell, 2007; Gann, Joann, Glynn, Buring, & Hennekens, 
1993). In a study of Cox-2 selective inhibitors, Bertagnoli et al. (2006) showed that 
Celecoxib reduced the risk of colorectal adenoma by 33-45% (RR-0.67 95% CI 0.59–
0.77 and RR- 0.55 95% CI 0.48–0.64, respectively) depending on the dose. It has also 
been shown that Celecoxib increases the risk of cardiovascular events, in those with an 
increased baseline risk for heart disease (Bertagnolli et al., 2009; Solomon et al., 2008). 
Unfortunately, many of the risk factors for heart disease and colorectal cancer are shared 
(On On Chan et al., 2007).  
 
Summary 
For all of the studied diseases, moderate to vigorous physical activity has been shown to 
be at least as effective, if not more effective than, pharmacological intervention. 
Furthermore, all pharmacological interventions discussed are recommended only for high 
risk populations due to adverse side effects. 
The physical activity research is not without limitations, however. A majority of these 
meta-analyses were limited by the use of relative measures of physical activity (Low, 
Moderate, High). Furthermore, these analyses focused on aerobic training of moderate 
and vigorous levels, there was little mention of resistance training. Lastly, a majority of 
the analyses presented, used a single baseline measure of physical activity in the form of 
a survey or questionnaire. A single baseline measure may be problematic in that the 
follow up periods involved in these studies was generally on the order of 4-12 years and a 
single measure of physical activity over that period would not adequately describe 
   43 
 
possible changes. It is also well established that survey and questionnaire measures of 
physical activity grossly over represent objective measures of physical activity, as was 
discussed in the Estimates of Compliance section.  
 
The American College of Sports Medicine Exercise is Medicine® 
Initiative 
The American College of Sports Medicine has spearheaded the campaign to integrate 
physical activity into clinical practice with the Exercise is Medicine® initiative. The 
primary goal of this initiative is to encourage primary care physicians and other primary 
healthcare providers to promote physical activity within their patient populations. This 
health initiative promotes the practice of assessing and prescribing physical activity at the 
primary care level of the healthcare system, in an effort to reduce levels of population 
physical inactivity. It is unclear how effective this initiative, which started in 2007, has 
been, as there is little data available to quantify its progress or effect. Preliminary data are 
not promising as estimates of primary care practitioners that engage patients in physical 
activity assessment and prescription activities during office visits have remained stable at 
around the 30% mark from 1999 to 2010 (P. M. Barnes & Schoenborn, 2012; Wee, 
McCarthy, Davis, & Phillips, 1999).  
The Exercise is Medicine® Healthcare Providers Action Guide (American College of 
Sports Medicine, 2016), provides a step by step guide towards the implementation of the 
Exercise is Medicine® process within an office visit, as well as resources for office use. 
The guide includes the following 5-step process, including suggested tools, for healthcare 
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providers to follow and use, during all routine office visits, 1) assess patient physical 
activity levels, using the Physical Activity Vital Sign (PAVS) 2) assess patient physical 
activity ability, using the Physical Activity Readiness Questionnaire (PAR-Q) 3) counsel 
patients to increase physical activity, utilizing the Exercise Stages of Change model 4) 
prescribe physical activity to patients using handwritten prescriptions 5) provide patients 
with referrals to exercise professionals when deemed necessary.   
 
Tools 
The Physical Activity Vital Sign was developed at the University of Utah, Department of 
Family and Preventative Medicine, for use by clinicians (Golightly et al., 2017). The tool 
consists of two questions, 1) “On average, how many days per week do you engage in 
moderate to strenuous exercise (like a brisk walk)?”, and 2) “On average, how many 
minutes do you engage in exercise at this level?” (American College of Sports Medicine, 
2016). In an effort to validate the Physical Activity Vital Sign Coleman et al. (2012) 
found that the results from a large-scale implementation of the Physical Activity Vital 
Sign into the electronic medical records of the Kaiser Permanente healthcare system were 
similar to the results of national surveys related to physical activity levels. This work 
showed that after a period of just one and a half years, it was possible to implement this 
tool into the electronic medical records of 86% of patients within the system. Further, 
Coleman et al. (2012) found a statistically significant, though clinically non-significant, 
relationship between the use of the Physical Activity Vital Sign and the outcome 
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measures, weight loss and HBa1C, over time (Grant, Schmittdiel, Neugebauer, Uratsu, & 
Sternfeld, 2014). 
The Physical Activity Readiness Questionnaire is a seven question screening tool used to 
determine whether or not patients have potential for negative heart and/or 
musculoskeletal related outcomes during engagement in physical activity (American 
College of Sports Medicine, 2016). A patient that answers “no”, to all seven questions is 
cleared for moderate intensity physical activity. A “yes” answer to any question is an 
indication that the patient is potentially at risk for a negative outcome from engagement 
in physical activity, and clinicians are advised to use their professional judgement in the 
prescription of physical activity in these cases. 
The Exercise Stages of Change Questionnaire consists of five questions and is used to 
determine the “Stage of Change” that a patient is currently in (American College of 
Sports Medicine, 2016). The stages of change model stems from the transtheoretical 
model of behavior change, pioneered by James O. Prochaska and Carlo Di Clemente in 
the late 1970’s and early 1980’s (Glanz, Rimer, & Viswanath, 2008). The model, 
amended for use within the Exercise is Medicine® initiative, consists of five distinct 
stages of change ranging from precontemplation, the patient has no intention of becoming 
physically active, to maintenance, the patient has met the physical activity 
recommendations regularly for 6 consecutive months. This model was born from 
smoking cessation research and has been applied to multiple behavior change domains 
since. This is one of the many parallel approaches between the fight against smoking and 
the fight against physical inactivity. 
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Implementation and Efficacy 
The Exercise is Medicine® initiative relies heavily upon primary care healthcare 
providers to implement the 5-steps into their daily clinical practice. However, providers 
are not financially incentivized to do so, and may not see the value in spending their time 
discussing physical activity with patients, especially when confronted with the myriad of 
other time-consuming tasks that they are responsible for executing (AuYoung et al., 
2016; Huijg et al., 2015; Lobelo, Duperly, & Frank, 2008; Peterson, 2007; Vuori, Lavie, 
& Blair, 2013). Further, dissemination of these guides and their contents is not required 
within the medical school curriculum making it reasonable to assume that many 
healthcare providers may be unaware of the Exercise is Medicine® Initiative altogether 
(Sallis et al., 2016).  
Little is known about the implementation or efficacy of the Exercise is Medicine® 
initiative as there is no data that directly reports outcomes related to either of these lines 
of query. What data is available does not support the notion that the initiative is being 
implemented in practice. In 1999, eight years prior to the inception of the Exercise is 
Medicine® initiative, Wee et al. (1999) reported that 34% of patients that had seen a 
doctor within the last twelve months reported receiving exercise related counseling. 
Thirteen years later (based on data from four years after the start of the initiative) Barnes 
and Schoenborn (2012) reported that 32.4% of patients reported the same result. This 
lack of change in exercise related counseling implies that the Exercise is Medicine® 
initiative is having little impact on the actions of primary care practitioners.  
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There have been no direct evaluations of the efficacy of the Exercise is Medicine® 
initiative. Indirect investigations into components of the 5-step process do not support the 
hypothesis that it is an effective strategy. AuYoung et al. (2016) states that “Findings on 
the impact of physical activity interventions in primary care have been mixed, due to 
insufficient follow-up or a lack of clarity about intervention intensity”. Similarly, Eden, 
Orleans, Mulrow, Pender and Teutsch (2002) state that “Evidence is inconclusive that 
counseling adults in the primary care setting to increase physical activity is effective.” 
These findings suggest that, although the Exercise is Medicine® initiative appears to 
have the support of major health institutions, including the American College of Sports 
Medicine, it may not be fully supported by the current literature. That is not to say that 
there are current reports that directly refute the current implementation status and efficacy 
of the project. 
 
Summary 
The Exercise is Medicine® initiative has been in operation for over a decade. In this time 
there have been no efforts to quantify whether or not it is being implemented into 
practice, or into the effect it is having on population physical activity levels. There is 
evidence that population physical activity levels are on the rise, however this trend cannot 
necessarily be attributed to the Exercise is Medicine® initiative, as it is unknown how 
many practitioners are aware of, and using, the 5-step process. There is clearly a gap in 
the literature for a critical analysis of the effectiveness of the EIM model in the clinical 
setting.  
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Economic Burden of Physical Inactivity on the US 
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Abstract  
Purpose 
The present study builds on previous works that date back more than two decades and do 
not include critical diseases that have been shown to be modifiable through physical 
activity such as Alzheimer’s disease, depression and breast cancer, by updating old 
analyses and including the most robust sample of diseases to date. Further, this is the first 
study to include an analysis of the potential ramifications of a national physical activity 
goal. The purpose of this analysis is to quantify the clinical and economic burden of 
physical inactivity on the US healthcare system, and to contextualize the effect of a 
realistic change in population physical activity levels according to the Healthy People 
2020 goals, in an effort to help practitioners and policymakers alike, understand the 
impact of the promotion of physical activity on the US healthcare system for the 
following conditions: cardiovascular disease, type II diabetes, depression, Alzheimer’s 
disease, breast cancer, colon cancer, and stroke.  
 
Methods 
Relative risks for each disease were retrieved from meta-analysis or systematic review, 
based on recency, quality, and number of included studies. Direct medical costs and 
prevalence estimates were retrieved from the most recent sources available. Population 
Attributable Risk (PAR) was calculated as PAR= (1+ Prf x (RR-1))/(Prf x (RR-1)), where 
Prf is the percentage of the U.S. population not meeting minimum exercise requirements 
and RR is the relative risk of disease for physically inactive, versus physically active 
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individuals. PAR was calculated for each disease under two conditions, based on 
differing previously-reported estimates of population physical inactivity levels; 56.6% 
and 90.4%. Main outcome measures include the annual number of clinical cases, and the 
total direct medical costs, attributable to physical inactivity for each disease, as well as 
potential savings in these terms, given successful completion of the Healthy People 2020 
goals. 
 
Results 
Physical inactivity is responsible for between 19-28 million clinical cases and between 
USD 109-155 billion in direct medical costs, annually. Reducing population physical 
inactivity by 4.4 percentage points, the decline necessary to meet the Healthy People 
2020 target, could potentially lead to a reduction of over 1 million cases and a savings of 
over USD 5 billion, annually. Moreover, a reduction in physically inactive persons by 
roughly 1 percentage point could potentially result in a quarter of a million cases of 
disease prevented and more than a billion dollars in savings, annually. 
 
Conclusion 
Healthcare practitioners and policymakers are in a position to effect population physical 
activity levels. Our results indicate that an increase in physical activity of less than 1% 
will lead to a quarter of a million cases prevented and over a billion dollars in savings. 
These findings alone should be enough to encourage the implementation of strategies 
aimed at increasing physical activity.   
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Introduction  
Physical inactivity is a growing health concern within the United States. It is estimated 
that 56.5-90.4% of adult Americans do not meet the minimum weekly physical activity 
requirements of 150 minutes of moderate, or 75 minutes of vigorous, physical activity per 
week (Haskell et al., 2007). Recent evidence from the Prospective Urban Rural 
Epidemiology (PURE) study, suggests that failure to achieve these minimum weekly 
requirements is associated with a 20-35% greater risk of all-cause mortality (Lear et al., 
2017). An established objective of the Healthy People 2020 campaign, a campaign 
updated decennially, directed at improving the health of all US citizens, is to increase the 
percentage of the U.S. population meeting the minimum weekly physical activity 
requirements by 10%, equivalent to a 4.4% decline in physically inactive persons. 
There is currently an epidemic of diseases related to physical inactivity (Alzheimer’s 
Association, 2015; Center for Behavioral Health Statistics and Quality, 2016; Mariotto et 
al., 2011; Mozaffarian et al., 2016b), with most studies indicating that the primary 
diseases related to a lack of adequate activity include cardiovascular disease, stroke, type 
II diabetes mellitus, Alzheimer’s disease, depression, and breast and colon cancers. These 
diseases hold three factors in common: they are all top ten causes of death in the United 
States (depression via suicide) (National Center for Health Statistics, 2016), are all 
associated with high direct medical costs (DMC) (Greenberg, Fournier, Sisitsky, Pike, & 
Kessler, 2015; Mariotto et al., 2011; Mozaffarian et al., 2016b; Wimo, Winblad, Jonsson, 
& Jo, 2010), and are all modifiable through physical activity intervention (Aune et al., 
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2015; Hamer & Chida, 2009; Johnson et al., 2013; Kyu et al., 2016; Sattelmair et al., 
2011; Silveira et al., 2013; Wu et al., 2013). 
The results of previous meta-analyses and systematic reviews on the interaction between 
physical activity and these diseases have shown that increasing physical activity is an 
effective preventative strategy, reducing the risk of developing any of these diseases by 
12-45% (Aune et al., 2015; Hamer & Chida, 2009; Johnson et al., 2013; Kyu et al., 2016; 
Sattelmair et al., 2011; Silveira et al., 2013; Wu et al., 2013).  Further, physical activity 
has been shown to be just as, if not more, effective than pharmacological intervention in 
treating these diseases (Alberti et al., 2007; Aune et al., 2015; Blondell et al., 2014; Cole 
et al., 2009; Diniz et al., 2009; Freedman et al., 2011; Hamer & Chida, 2009; Jeon et al., 
2007; Johnson et al., 2013; Kyu et al., 2016; Law et al., 2009; Li et al., 2013; Li & 
Siegrist, 2012; Naci & Ioannidis, 2013; Robsahm et al., 2013; Sattelmair et al., 2011; 
Silveira et al., 2013; Francesco Sofi et al., 2008; Wegner et al., 2014; Wu et al., 2013).  
This efficacy-related evidence has spurred a push to implement physical activity as 
preventative medicine within the healthcare system. The American College of Sports 
Medicine has spearheaded the campaign to integrate physical activity into clinical 
practice with the Exercise is Medicine® initiative. This health initiative promotes the 
practice of assessing and prescribing physical activity at the primary care level of the 
healthcare system in an effort to reduce levels of population physical inactivity. It is 
unclear how effective this initiative, which started in 2007, has been, as there is little data 
available to quantify its progress. Preliminary data are not promising as estimates of 
primary care practitioners that engage patients in physical activity assessment and 
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prescription activities, during office visits, have remained stable at around the 30% mark 
from 1999 to 2010 (P. M. Barnes & Schoenborn, 2012; Wee et al., 1999).  
Although the burden of physical inactivity on the US healthcare system has previously 
been analyzed, it is important to update and build on our understanding, periodically. 
Previous analyses, using similar methods, date back more than two decades and do not 
include critical diseases that have been shown to be modifiable through physical activity 
such as Alzheimer’s disease, depression and breast cancer. Also, these analyses failed to 
put the burden of physical inactivity into a context meaningful to current practitioners 
and policy makers. 
Quantifying the burden of physical inactivity, in terms of number of clinical cases and 
direct medical costs in the United States, will help to contextualize the problem of 
physical inactivity, relative to other health concerns, for practicing clinicians. Then, 
analyzing the potential case- and cost-savings effect of a current physical activity 
initiative, will put into perspective how much change a program, such as the Healthy 
People 2020 campaign, can have on the US healthcare system. The objective of the study 
reported herein was to determine the number of clinical cases, the total direct medical 
costs attributable to physical inactivity and the potential case- and cost-savings effect, of 
a current physical activity initiative, for the following conditions: cardiovascular disease, 
type II diabetes, depression, Alzheimer’s disease, breast cancer, colon cancer, and stroke. 
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Methods 
Disease Inclusion Criteria 
The diseases included in this study were selected based on three criteria. First, each 
disease had to be listed as a top ten cause of death in the United States according to the 
most recent statistics presented by the National Center for Health Statistics (National 
Center for Health Statistics, 2016). Second, the disease had to be associated with annual 
direct medical costs in excess of USD 15 billion. Lastly, the Relative Risk (RR) for each 
disease had to be shown to be modifiable through physical activity. A summary of 
disease type, disease prevalence, cause of death rank, direct medical cost, and the relative 
risks used for calculations, can be found in Table 1.  
 
Prevalence 
Estimates of disease prevalence were obtained following a systematic search of Pubmed, 
Google Scholar and SPORT discus. The most recent estimates available from the most 
reliable sources were selected.  
 
Direct Medical Cost 
Each direct medical cost estimate, which included cost of inpatient care, prescription 
medication, outpatient and office-based provider visits, hospitalization and hospital costs, 
physician cost, nursing home care and home health care, was obtained following a 
systematic search of Pubmed, Google Scholar and SPORT discus. The most recent 
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estimate of direct medical cost was used in each case and adjusted, using the consumer 
price index, to 2016 USD. 
 
Relative Risks 
Meta-analyses and systematic reviews containing relative risk values for each disease 
were identified by searching PubMed, Google Scholar and SPORT discus. Articles were 
selected for use in this study based on recency, scope, and similarity of physical activity 
classification. For the purpose of this analysis, a participant was considered physically 
inactive if they failed to satisfy the weekly minimum exercise requirements of 150 
minutes of moderate, or 75 minutes of vigorous activity, and physically active if they 
accomplished these requirements. Preference was given to studies that classified active 
and non-active individuals in these terms.  
 
Population Attributable Risk 
Population Attributable Risk (PAR) is an estimate of the proportion of the people within 
a diseased population attributable to a specific risk factor. In our case, the specific risk 
factor was physical inactivity. PAR was calculated for each disease, as it has been in 
similar studies (D. E. Barnes & Yaff, 2011; Katzmarzyk, Gledhill, & Shephard, 2000), 
using the formula:  
PAR= (Prf x (RR-1))/(1 + Prf x (RR-1)) 
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Prf is the percentage of the U.S. population considered physically inactive and RR is the 
relative risk of disease for a physically inactive, compared to a physically active, 
individual.  
 
Determination of Prf 
Citing NHIS survey data, the Healthy People 2020 goals campaign reports that, in 2008, 
56.5% of US adults over the age of 18 were physically inactive. However, Tucker, Welk 
and Beyler (2011) analyzed 2005-2006 NHANES data and reported a large disparity in 
estimates of population physical inactivity based on study methodology. In their analyses, 
38% of participants were considered physically inactive according to survey results, 
whereas 90.4% of adults were considered physically inactive when monitored for 7 
consecutive days via direct accelerometry. For this reason, PAR was calculated twice. 
First PAR was calculated based on the NHIS survey data using a Prf of 0.565, and second 
PAR was calculated based on NHANES accelerometry data using a Prf of 0.904 
 
Savings Analyses 
The Healthy People 2020 goals campaign set a goal to increase the number of Americans 
satisfying the weekly minimum exercise requirements by 10%. This 10% increase in 
population physical activity represents a 4.4 percentage point decrease (56.5%-52.1%) in 
those considered physically inactive.  
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The first savings analysis (SurveyData) was conducted using the PAR estimate based on 
NHIS survey data and the assumption that a 10% increase in population physical activity 
was achieved, per the Healthy People 2020 goals campaign. 
The second analysis (Accel10%) was conducted using the PAR estimate based on 
NHANES accelerometry data and the assumption that a 10% increase in population 
physical activity was achieved. Importantly, a 10% increase in the percentage of the 
population considered physically active, given that only 9.6% of the population was 
considered physically active at baseline, leads to an absolute decrease in those considered 
physically inactive, of only 0.96 percentage points; a much smaller absolute change than 
initially intended by the Healthy People 2020 goals campaign. For this reason, a third 
analysis was conducted. 
The third analysis (Accel4.4) was conducted using the PAR estimate based on NHANES 
accelerometry data and the assumption that an absolute decrease in physical inactivity of 
4.4 percentage points was achieved. 
 
Potential Cases Prevented 
Potential cases prevented for each analysis were calculated as:  
Potential Cases Prevented= (PAR1 x Prevalence) - (PAR2 x Prevalence) 
Where PAR1 was calculated using the baseline Prf, and PAR2 was calculated using the 
Prf given the accomplishment of the assumed goals. For the SurveyData analysis, PAR1 
was calculated with the baseline Prf of 0.565, and PAR2 was calculated using a Prf of 
0.521, representing a 10% increase in those considered physically active from baseline, 
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and an absolute decrease in those considered physically inactive of 4.4 percentage points. 
For the Accel10% analysis, PAR1 was calculated with the baseline Prf of 0.904, and 
PAR2 was calculated using a Prf of 0.894, representing a 10% increase in those 
considered physically active from baseline.  For the Accel4.4 analysis, PAR1 was 
calculated with the baseline Prf of 0.904, and PAR2 was calculated using a Prf of 0.860, 
representing an absolute decrease in those considered physically inactive of 4.4 
percentage points from baseline.  
 
Potential Savings in Direct Medical Costs 
Potential savings in direct medical costs, for each condition and scenario were calculated 
as: 
 Potential DMC Savings = Potential Cases Prevented x DMC Per Case 
Where DMC Per Case was calculated as: 
DMC Per Case= Total Direct Medical Cost of Disease/Prevalence of Disease 
 
Results 
Total Clinical Cases and Direct Medical Costs Attributable to Physical Inactivity 
When PAR was calculated for the SurveyData analysis, based on survey data from the 
NHIS, the total clinical cases attributable to physical inactivity for all diseases combined, 
annually, were 28.2 million. The total direct medical costs attributable to physical 
inactivity for all diseases combined were USD 154.61 billion, annually.  
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When PAR was calculated for both the Accel10% and Accel4.4 analyses, based on 
accelerometry data from the NHANES, the total clinical cases attributable to physical 
inactivity for all diseases combined, annually, were 19.5 million. The total direct medical 
costs attributable to physical inactivity for all diseases combined were USD 109.21 
billion, annually. 
Total clinical cases and direct medical costs attributable to physical inactivity for each 
disease are listed in Table 3. 
 
SurveyData Analysis 
The SurveyData analysis assumed that at baseline 56.5% of the population was 
physically inactive and that a 10% increase in population physical activity was achieved, 
reducing population physical inactivity by 4.4 absolute percentage points. This analysis 
estimated that 1,267,548 clinical cases would be prevented and USD 6.55 billion in direct 
medical costs would be saved, annually. 
 
Accel10% Analysis 
The Accel10% analysis assumed that at baseline, 90.4% of the population was physically 
inactive and that a 10% increase in population physical activity was achieved, reducing 
population physical inactivity by 0.96 absolute percentage points. This analysis estimated 
that 227,443 clinical cases would be prevented and USD 1.11 billion in direct medical 
costs would be saved, annually. 
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Accel4.4 Analysis 
The Accel4.4 analysis assumed that at baseline, 90.4% of the population was physically 
inactive and that a reduction in population physical inactivity levels of 4.4 absolute 
percentage points was achieved. This analysis estimated that 1,051,640 clinical cases 
would be prevented and USD 5.17 billion in direct medical costs would be saved, 
annually. 
 
All Analyses 
For all analyses, cardiovascular disease was the disease type with the greatest number of 
Potential Cases Prevented, whereas type II diabetes mellitus was the disease type with the 
greatest Potential DMC Savings. Alzheimer’s Disease was associated with the highest 
PAR values, whereas breast and colon cancer were associated with the lowest. These 
differences were due to their respective relative risk values. Alzheimer’s Disease was 
associated with the highest DMC Per Case ($14,662.26) whereas cardiovascular disease 
was associated with the lowest ($2,192.52). A summary of the Potential Clinical Cases 
Prevented and Potential DMC Savings for each analysis are presented in Table 4. 
Table 2 provides a summary of the relative risk for each disease studied, given both 
physical activity and pharmacological intervention. Although physical activity has been 
demonstrated to be as effective as pharmacotherapy in many settings, the adherence to 
physical activity is lower than pharmacologic intervention. It is important to note that all 
pharmacological interventions are associated with some level of negative side effects in a 
portion of the patient population. Whereas some level of physical activity can be 
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prescribed to a large portion of the population as a preventative measure, with less regard 
for side effects. Physical activity has the advantage of working to treat all of the diseases 
related to physical inactivity at once as a “one size fits all” prescription. 
 
Discussion 
The primary findings of our analysis show that between 19-28 million cases of disease 
and between USD 109-154 billion in direct medical costs can be attributed to physical 
inactivity annually. Furthermore, our analysis is the first to demonstrate that a decrease in 
the percentage of the population considered physically inactive of 4.4 points (Healthy 
People 2020 goal), will lead to the prevention of more than 1 million clinical cases and 
over USD 5 billion in savings of direct medical costs annually, regardless of Prf estimate. 
Impressively, a decrease in population physical inactivity levels of just 0.96 percentage 
points was shown to lead to a quarter of a million cases prevented and over USD 1 billion 
in direct medical cost savings, annually. These findings suggest that physical activity 
interventions capable of increasing the percentage of the population meeting the 
minimum weekly exercise requirements by as little as 1 percentage point may be worth 
USD 1 billion in direct medical cost savings. These results, combined with the 
knowledge that physical activity is as effective as pharmacological intervention, without 
the adverse side effects, gives considerable insight into the power of physical activity as a 
preventative medical intervention.  
To date there have been two analyses of the economic burden of physical inactivity, 
using the population attributable risk method, on the US healthcare system (Colditz, 
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1999; Garrett, Brasure, Schmitz, Schultz, & Huber, 2004), and one global analysis that 
included the US, amongst 143 other countries (Ding et al., 2016). Colditz (1999) and 
Garrett, Brasure, Schmitz et al. (2004) relied upon data that is almost two decades old for 
their analyses, at a time when our understanding of the relative risk of disease, based on 
exercise status, was so limited that there was debate as to whether or not physical activity 
had a protective effect on breast cancer, and total healthcare spending was roughly one 
third of what it is today. Further, Garrett, et al. (2004) focused solely on the Minnesota 
healthcare system, providing no insight into the effects of physical inactivity nationwide. 
Ding, Lawson, Kolby-Alexander, et al. (2016) did not include Alzheimer’s Disease or 
depression, the sixth and tenth (via suicide) leading causes of death in the US, 
respectively, in their analysis of the global burden of physical inactivity. Further, none of 
these reports quantify the number of cases of each disease attributable to physical 
inactivity or estimate the potential case and cost savings based on the proposed goals of a 
current national health initiative. 
In an analysis of the economic costs of inactivity in the United States, Colditz (1999) 
found that physical inactivity, as defined by “no reported leisure time physical activity”, 
cost between USD 38.27 and 58.58 billion (adjusted from 1995 to 2016 dollars), or 
between 2.4 and 3.7% of total healthcare spending, annually. Since that time, total 
healthcare spending has roughly tripled to 3.3 trillion dollars annually (Centers For 
Medicare and Medicaid Services, 2016). Based on our findings we can conclude that the 
cost of physical inactivity in the United States, USD 109-154 billion, has increased at a 
rate greater than inflation and the percentage of total healthcare spending due to physical 
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inactivity, has potentially increased, as our data would suggest that it is currently between 
3.3 and 4.7% (109B/3.3T, 1545B/3.3T). 
Ding, et al. (2016), in a report on the global economic burden of physical inactivity, 
found the cost of physical inactivity in the US to be between 8.6 and 58.6 2013 
international dollars, equivalent to between USD 8.86 and 60.37 billion in 2016. 
However, this analysis did not include Alzheimer’s Disease or depression, which 
accounted for USD 47.0 and USD 64.8 billion dollars in our analysis, respectively. 
Removing the cost of these two diseases brings our estimate to between USD 62 and 
USD 89.2 billion. 
 In a study of the economic impact of physical activity on cardiovascular disease, Wang 
et al. (Wang, Pratt, Macera, Zheng, & Heath, 2004), found that 9.2 million cases and 
USD 23.7 billion in direct medical costs of cardiovascular disease were attributable to a 
lack of physical activity. These values fall within the ranges for total cases (NHIS Survey 
Data - 10,819,840, NHANES Accelerometry Data- 7,096,240) and DMC savings (NHIS 
Survey Data - $23.72 B, NHANES Accelerometry Data - $15.56 B) attributable to 
physical inactivity estimated for cardiovascular disease in our analyses. 
 Our analyses build on previous works by studying more disease states, calculating PAR 
under multiple conditions, and estimating the economic impact of changes to current 
levels of population physical inactivity according to real world goals. 
Our findings also suggest that the economic burden of physical inactivity is similar to that 
of tobacco use. According to the American Cancer Society (Eriksen, Mackay, Schluger, 
Gomeshtapeh, & Drope, 2015), tobacco related healthcare costs have been estimated to 
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be USD 133 billion annually and Xu et al. (2015) estimated that in 2010 smoking-
attributable healthcare spending totaled USD 170 billion. Compare these estimates of 
tobacco related healthcare estimates to our findings of physical inactivity related 
healthcare costs of between USD 109-154 billion annually. In similar fashion, a year 
2000 investigation into the economic burden of physical inactivity in Canada found that 
the healthcare costs attributable to physical inactivity and smoking were similar in the 
Canadian healthcare system (Katzmarzyk et al., 2000), as well. These findings suggest 
that efforts to reduce physical inactivity levels should be on par with those directed at 
reducing smoking levels. 
Preferring lower but also more stringent and less speculative cost estimates, we 
considered direct medical costs only, and by not considering indirect and intangible costs 
associated with each disease, provide more defensible, though more conservative, 
estimates of economic burden. Furthermore, the results reported here are based on 
estimations of time spent participating in physical activity. No measure of fitness, or 
change in fitness due to physical activity, was accounted for, but should be incorporated 
in future studies. Conceivably, a research question to be evaluated concerns how the 
effects of improved physical fitness versus time spent participating in physical activity 
translate into healthcare savings. We also recognize the quality and relevance of our 
source data within the availability of quality estimates. Relative risk values were 
retrieved from the highest quality sources available; however, not all sources used the 
minimum weekly exercise recommendations as criterion for group stratification. Many 
such sources used relative values of physical activity, stratifying participants in to low 
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and high activity groups. Direct medical cost and prevalence estimates were from the 
most recent sources available, however in a few cases these reports were from as far back 
as 2010. To stay on the conservative side, we adjusted all direct medical costs to 2016 
dollars based on the general consumer price index (CPI), as the medical CPI is based on a 
narrower basket of goods and services and would have yielded even greater cost 
estimates. Here too, in keeping with our preference for lower and more robust estimates, 
we preferred a conservative approach. Lastly, in our estimate of Prf for exposure to 
physical inactivity we had to reconcile several methods to determine the percentage of 
the population considered to be physically inactive. To resolve this, we calculated PAR 
under multiple conditions and scenarios. 
 
Conclusion 
Physical inactivity, an established problem in the US and several other Western countries, 
and of significant concern in evolving economies, has been linked convincingly to 
significant increases in clinical cases of multiple, highly prevalent diseases; in turn, with 
marked morbidity, mortality, and substantial direct medical costs. Physical inactivity has 
also been demonstrated to be just as, if not more, effective in treatment compared to 
pharmacological intervention, without the risk of adverse side effects. 
Our analysis establishes that the clinical and economic burden of physical inactivity to 
the US healthcare system, both in terms of population affected and direct healthcare 
expenditures involved, parallels that of smoking. For this reason, public health initiatives 
aimed at reducing physical inactivity should be similar to those aimed at reducing 
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tobacco use. Furthermore, our analysis demonstrated that a reduction in population 
physical inactivity levels of 4.4 percentage points, an established objective of the Healthy 
People 2020 campaign, will prevent over 1 million cases of disease, as well as savings of 
over USD 5 billion in direct medical costs, annually. Further, we found that a change in 
population physical activity levels of less than 1 percentage point could lead to a quarter 
of a million fewer cases of disease and over USD 1 billion in direct medical cost savings. 
These findings should encourage healthcare practitioners and policymakers alike to 
advocate for increased physical activity.  
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Abstract  
Purpose 
The Exercise is Medicine® (EIM®) initiative has proposed a strategy in which primary 
care practitioners advocate for increased physical activity within their patient 
populations, to increase population level physical activity. This strategy is heavily 
dependent upon the participation of primary care practitioners, however little is known as 
to the viewpoint of these practitioners related to this strategy. The purpose of this study is 
to assess primary healthcare providers familiarity with, current implementation of, and 
attitudes towards, the EIM® initiative. 
 
Methods 
A 5-section, random ordered, survey consisting of 30 questions, was distributed to 10,758 
primary care practitioners in the united states, via email.  
 
Results 
Overall, primary care practitioners “neither agreed or disagreed” that it is within their 
scope of practice to be executing all five steps of the EIM® process at every office visit.  
Whereas, they “somewhat agreed” that four out of the five steps of the EIM® process are 
within their scope of practice. Of the primary care practitioners surveyed, 68.27% had 
never heard of EIM® initiative, and only 5.77% of respondents had heard of the 
initiative, knew of its purpose and were aware of the 5-step process. On a scale ranging 
from strongly agree, to strongly disagree, primary care practitioners “did not agree or 
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disagree” that the strategy proposed by the EIM® is within their scope of practice. It was 
also found that doctors are less likely than non-doctors to support the EIM® process. 
Zero respondents indicated that they thought the 5-step EIM® process would have a 
negative effect on population physical activity, while 73.08% of respondents felt that it 
would slightly increase population physical activity levels. 
 
Conclusion 
Our findings suggest that a large proportion of primary care practitioners are unaware of 
the EIM® initiative and they do not feel that the proposed strategy is within their scope of 
practice. However, they do feel that it would have only a positive impact on population 
physical activity levels. Importantly, doctors are less likely than non-doctors to agree that 
they should be executing all of the steps of the 5-step process at every office visit. Our 
findings suggest that primary care practitioners are largely unaware of the Exercise is 
Medicine® initiative and they do not feel that it is within their scope of practice. Based 
on these findings, it is recommended that the EIM® initiative increase visibility of their 
program, educate primary care practitioners as to how to implement the program, and 
take steps towards reducing the amount of time required of practitioners. These steps 
should include a streamlined version of the 5-step process, as well as transitioning the 5-
step process to annual use.  
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Introduction 
The American College of Sports Medicine (ACSM), among other health and exercise 
institutions around the world, recommends 150 minutes of moderate, or 75 minutes of 
vigorous intensity physical activity per week in order to promote and maintain good 
health(Haskell et al., 2007). Recent evidence from the Prospective Urban Rural 
Epidemiology (PURE) study supports these standards, as failure to achieve them is 
associated with a 20-35% increased risk for all-cause mortality (Lear et al., 2017). In an 
effort to increase the proportion of the population accomplishing the recommended levels 
of physical activity, the ACSM established the Exercise is Medicine® (EIM) initiative in 
2007. 
Multiple efforts have been made to quantify the proportion of the U.S. population that 
regularly meet the weekly recommendations for physical activity. Differences in 
methodological approaches has led to a wide range of estimates making interpretations 
difficult (Troiano et al., 2008; Tucker et al., 2011). For example, Tucker et al. (2011) 
found a discrepancy between self-reported data and data collected via 7-day continuous 
accelerometry. In this report, 62.0% of Americans met the weekly physical activity 
requirements when asked to self-report, whereas only 9.6% of Americans met the 
requirements according to accelerometry data. In an earlier report, Troiano et al. (2008) 
found similar discrepancies between self-report and accelerometry methods, and 
suggested that great care must be taken when interpreting self-reported physical activity 
data. However, the authors also suggested that the two methods are similarly discrepant 
regarding patterns of activity across gender and age groups. More recent reports, based 
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on self-reported data, suggest a pattern of increased physical activity amongst U.S. adults 
between 2008-2015. Specifically, the proportion of U.S. adults meeting weekly physical 
activity requirements has increased from 43.5% in 2008, to 49.8% in 2015, with a peak  
of 50% in 2012 (US Department of Health and Human Services, 2014).  
Increasing the proportion of the population that meets the weekly physical activity 
requirements is an important goal, as meeting these requirements is associated with up to 
a 45% reduced risk of lifestyle diseases (Aune et al., 2015; Hamer & Chida, 2009; 
Johnson et al., 2013; Kyu et al., 2016; Sattelmair et al., 2011; Silveira et al., 2013; Wu et 
al., 2013) including cardiovascular disease, stroke, type II diabetes mellitus, Alzheimer’s 
disease, breast cancer, colon cancer and depression (Rourk, Abraham, Olson, & Snyder, 
2018). Further, physical activity intervention has been shown to treat these diseases as 
well as, or better than, pharmacological intervention (Cole et al., 2009; Diniz et al., 2009; 
Freedman et al., 2011; Law et al., 2009; Naci & Ioannidis, 2013). 
These particular lifestyle diseases, taken as a group, have reached epidemic levels with an 
estimated combined prevalence of over 145 million diagnosed cases and direct medical 
costs in excess of USD 605 billion, annually (Rourk, Abraham, et al., 2018). Further, 
between 19 and 28 million of these diagnosed cases and between USD 109 and 154 
billion of the associated direct medical costs have been attributed to physical inactivity 
(Rourk, Abraham, et al., 2018). It has been estimated that an increase in the proportion of 
the U.S. population that meets the weekly physical activity requirements by 4.4 absolute 
percentage points can lead to the prevention of over 1 million diagnosed cases and a 
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savings in excess of USD 5 billion in direct medical costs, annually (Rourk, Abraham, et 
al., 2018). 
The prevalence and costs associated with physical inactivity, combined with the 
preventative efficacy of physical activity, led to the establishment of the Exercise is 
Medicine® initiative by the American College of Sports Medicine (ACSM) in 2007. The 
primary goal of this initiative is to encourage primary care physicians and other 
healthcare providers to promote physical activity within their patient populations 
(American College of Sports Medicine, 2016). The Exercise is Medicine®, Healthcare 
Providers Action Guide (American College of Sports Medicine, 2016), provides a step by 
step guide towards the implementation of the Exercise is Medicine® process within an 
office visit, as well as resources for office use. The guide includes the following 5-step 
process for healthcare providers to follow during all routine office visits, 1) assess patient 
physical activity levels, using the Physical Activity Vital Sign (PAVS), 2) assess patient 
physical activity ability, using the Physical Activity Readiness Questionnaire (PAR-Q), 
3) counsel patients to increase physical activity, utilizing the Exercise Stages of Change 
model, 4) prescribe physical activity to patients using handwritten prescriptions, and 5) 
provide patients with referrals to exercise professionals when deemed necessary.   
The Exercise is Medicine® initiative relies heavily upon primary care healthcare 
providers to implement these steps into their daily clinical practice. However, providers 
are not financially incentivized to do so, beyond their normal care, and may not recognize 
the value in spending clinical time discussing physical activity with patients, especially 
when confronted with the myriad of other time-consuming tasks that they are responsible 
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for (AuYoung et al., 2016; Huijg et al., 2015; Lobelo et al., 2008; Peterson, 2007; Vuori 
et al., 2013). Further, dissemination of these guides and their contents is not required 
within the medical school curriculum, making it reasonable to assume that many 
healthcare providers may be unaware of the Exercise is Medicine® Initiative altogether 
(Sallis et al., 2016).  
While previous studies have assessed barriers to the implementation of physical activity 
based healthcare strategies by healthcare professionals (AuYoung et al., 2016; Huijg et 
al., 2015; Vuori et al., 2013), no study has focused on the attitudes of the primary care 
practitioner towards the Exercise is Medicine® initiative. Due to the reliance on the 
primary care practitioner to execute the Exercise is Medicine® initiative, it is vitally 
important to understand their perspective. The purpose of this study is to assess primary 
healthcare providers familiarity with, current implementation of, and attitudes towards, 
the Exercise is Medicine® initiative. 
 
Methods 
Study Population 
A random sample of 10,003 healthcare providers nationwide, including 1,429 of each, 
family practitioners, pediatricians, geriatricians, internists, obstetrician-gynecologists, 
nurse practitioners and physicians assistants was generated from the American Medical 
Association (AMA) Masterfile database by way of the third-party licensor, Redi-Data. A 
convenience sample of 755 family practitioners, internal medicine/pediatric physicians 
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and pediatricians, practicing in North Dakota, South Dakota, Minnesota, Wisconsin and 
Iowa was procured from the marketing department of a local hospital. 
For inclusion, practitioners had to be currently practicing, with primary care patients as a 
part of their patient population. 
 
Survey Instrument 
With the assistance of experts in survey design from the Office of Measurement Services 
at the University of Minnesota, the survey instrument used in this study was designed to 
assess the primary healthcare providers familiarity with, current implementation of, and 
attitudes towards, the Exercise is Medicine® initiative. A copy of the full survey can be 
found in the appendix. In all cases, the first and second sections of the survey were 
presented in order. In the first section demographic information was obtained and 
included: specialty type, medical training type (Medical Doctor or Doctor of Osteopathy), 
the percentage of primary care patients seen in practice, career length, practice type, sex, 
date of birth and state in which practice is conducted. The second section included a 
description of the Exercise is Medicine® initiative, along with a description of the 5-step 
Exercise is Medicine® process outlined in the action guide and a single question directed 
at their familiarity with the initiative and the process. After the first two sections were 
answered, sections three through five were presented in random order, to control for any 
potential order effects. Section three contained questions related to the participants 
current clinical use of any, and/or, all of the steps of the Exercise is Medicine® 5-step 
process. The fourth section contained questions related to whether or not participants felt 
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that any, and/or, all of the steps of the Exercise is Medicine® process are within their 
scope of practice. The fifth section of the survey contained the single question, “If all 5 
steps of the EIM® process were carried out by all primary care practitioners during all 
office visits, how would the physical activity level of the patient population be 
affected?”. This question was intended to assess participants attitudes towards the 
potential efficacy of the Exercise is Medicine® initiative.   
The survey was pretested by a focus group of four primary care practitioners for ease of 
use, timing and completeness. 
The Cronbach’s Alpha test was used to verify reliability of the survey. Each respondent’s 
average response to the five questions in section four directed at understanding 
practitioners attitude towards each individual step of the EIM® process falling within 
their scope of practice, was compared to their response to a question in which 
respondents were asked if executing all five steps of the EIM® process was within their 
scope of practice. This analysis revealed a Cronbach’s Alpha of .871, demonstrating that 
the survey is indeed, reliable. 
 
Statistical Methods  
Prior to collecting data, a sample size calculation assuming a power of 0.80, an alpha of 
0.05 and a moderate effect size of 0.3 resulted in a minimum sample requirement of 88 
completed surveys.  
Overall data was presented as percentage of total respondents.  
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For post-hoc comparison analyses between awareness status (Aware vs. Unaware), 
geographical status (MN vs. Non-MN) and medical degree status (Doctor vs. Non-
Doctor), answers to questions were scaled one through seven, where 1 represented 
strongly agree and 7 represented strongly disagree, to allow for comparison of means in 
accordance with recent statistical recommendations from the literature (de Winter & 
Dodou, 2010; Wadgave & Khairnar, 2016). Means were compared by way of Levene’s 
test for equality of variances and two-tailed t-tests.  
To determine the effect of geographical status, medical degree status or an interaction 
between the two, a 2 x 6 ANOVA was performed on the questions from section 4 that 
were found to have significant between group differences under both analyzed 
conditions. An alpha level was set at 0.05 for determination of statistical significance. All 
statistical analyses were performed using SPSS (IBM, Armonk, New York). 
 
Results 
Out of a sample of 10,758, we received 104 completed surveys. Overall, 82% of 
respondents were doctors, of which 87% described themselves as medical doctors. 
Family practitioners represented 46% of the overall respondents and 56% of the doctors, 
whereas nurse practitioners represented 13% of the overall respondents and 74% of the 
non-doctors. Overall, 79% of respondents reported that between 76 and 100% of their 
patients seen in practice were primary care and 62% of respondents reported being in 
practice for greater than 15 years. The average age was 52.27 with a range between 32 
and 78. Full results can be found in Table 5.   
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In section four, respondents were asked about their attitude towards the EIM® initiative 
and their scope of practice. These questions were scored on a 7-point likert scale, ranging 
from “strongly agree” (1) to “strongly disagree” (7), with the option to “neither agree nor 
disagree” (4). Results from section four indicated that overall, primary care practitioners 
“neither agreed or disagreed” that they should be executing all five steps of the EIM® 
process at every office visit. Respondents “somewhat agreed” that four out of the five 
steps of the EIM® process are within their scope of practice (range- 2.57-3.26). On 
average, respondents “neither agreed or disagreed”, that handwriting prescriptions was 
within their scope of practice as the average response was 3.95. Full results, questions 
and possible responses can be found in Figures 1 and 2.  
Results from section two of the survey indicated that 68.27% of the primary care 
practitioners surveyed had never heard of Exercise is Medicine®. Only 5.77% of 
respondents had heard of the initiative, knew of its purpose and were aware of the 5-step 
process. A post-hoc analysis comparing the 5.77% of practitioners that were aware of the 
EIM® to those that were not revealed that the two groups do not execute the steps of the 
EIM at differing levels, with the exception being that primary care practitioners aware of 
the EIM® are more likely to use the Exercise Stages of Change model when 
implementing behavioral counseling strategies with their patients. Complete results from 
this section can be found in Figure 3.  
Results from section three indicated that 91.35% of surveyed primary care practitioners 
self-reported that they never use all five steps of the EIM® process with their patients. 
Further, 98.02%, 96.55% and 60.92% of respondents indicated that they did not use the 
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PAVS, the PAR-Q and the Exercise Stages of Change model, respectively, when carrying 
out the associated step in the process. Full results from section three can be found in 
Figures 4-7. 
In section five, zero respondents indicated that they thought the 5-step EIM® process 
would have a negative effect on population physical activity, while 73.08% of 
respondents felt that it would slightly increase population physical activity levels. 
Complete results are shown in Figure 8. 
Of the completed surveys, 39 (37.5% of all respondents) came from the random sample 
of 10,003 healthcare providers, whereas 65 (62.5% of all respondents) came from the 
convenience sample of 755 midwestern physicians. Of the 65 surveys from the 
convenience sample, 59 (56.7% of all respondents) were completed by primary care 
practitioners practicing in the state of Minnesota. This discrepancy in response rate, 
related to geographical location, is likely attributable to the fact that the email contained 
University of Minnesota logos, per university research guidelines. In total, 24 states were 
represented, however the average number of representative surveys per state was 1.9, 
excluding surveys from Minnesota based respondents. 
Due to this sampling issue, survey results were compared between Minnesotan and non-
Minnesotan respondents. It was discovered that the Minnesotan respondents were 
significantly more likely to be doctors as compared to non-doctors. This led to a 
secondary comparison of medical degree status (doctor vs. non-doctor). In both 
secondary analyses, significant differences in response were found in section four, for 
questions 48-51 and 53. The results of these analyses are summarized in Figures 9 and 
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10. To determine the effect of medical degree status, geographical status, or an 
interaction, a 2 x 6 ANOVA was performed. According to the ANOVA analysis, the 
effect of medical degree status was significant for four questions in which respondents 
were asked how strongly they agreed with statements that asked if they should be, 
“assessing patient physical activity levels”, “utilizing behavioral counseling strategies 
directed at increasing physical activity”, “providing written prescriptions for physical 
activity”, or “executing all 5 steps of the EIM® process”, during every office visit.  
Geographical status was not significant for any question, and there was no interaction.  
 
Discussion 
The purpose of this study was to assess, via survey, primary healthcare providers 
familiarity with, current implementation of, and attitudes towards, the Exercise is 
Medicine® initiative. Our results suggest that primary care providers, regardless of 
medical degree status or geographical location, are largely, unaware of the Exercise is 
Medicine® initiative. Given the limited awareness of the Exercise is Medicine® initiative 
it is not surprising that 91.35% of respondents admit to never executing all 5 steps of the 
Exercise is Medicine® process with their patients. When analyzed separately, doctors 
“somewhat disagreed”, when asked if executing all five steps of the Exercise is 
Medicine® process at every office visit is within their scope of practice. Less 
beleaguering are the findings that none of the primary care providers surveyed, thought 
that the Exercise is Medicine® process would have a negative impact on patient physical 
activity levels. When asked how the implementation of the Exercise is Medicine® 
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initiative would affect the population physical activity level, the majority of providers 
stated that they believed it would slightly increase physical activity levels.  
In a survey of patients published in 1999 using data from 1995, 12 years before the 
initiation of the Exercise is Medicine® Initiative, Wee, McCarthy, Davis and Phillips 
(Wee et al., 1999), found that 34% of respondents that had seen a doctor in the past 12 
months were counseled to engage in physical activity. Similarly, in 2012 the NCHS 
reported that 32.4% of patients surveyed in 2010, three years after the creation of the 
Exercise is Medicine® initiative, that had seen a doctor in the past 12 months were 
counseled to engage in physical activity(P. M. Barnes & Schoenborn, 2012). Based on 
these findings it may seem logical to conclude that roughly one-third of doctors engage 
patients in physical activity related healthcare strategies, however, our findings suggest 
that doctors use discretion when choosing which patients to implement exercise related 
healthcare strategies and that they don’t necessarily follow the Exercise is Medicine® 
strategy. This trend is especially true in the case of the first three steps of the process 
(physical activity level assessment, physical activity ability assessment and behavior 
change counseling), where at least 83.65% of respondents claimed to execute each of the 
steps with at least 1% of their patients for each step. The last two steps of the Exercise is 
Medicine® process (providing a handwritten prescription and referral to an exercise 
professional) are far less likely to be executed during a patient visit however, with 62.5% 
and 45.2% of respondents claiming to have never executed these steps, respectively, with 
their patients.    
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Though it has been demonstrated that the Physical Activity Vital Sign can be 
implemented within a large healthcare system (Coleman et al., 2012), the results of our 
study suggest that its use has not been widely adopted. The same can be said of all of the 
tools suggested to be used within the Exercise is Medicine® process, as, of the 
practitioners that do implement the steps associated with the Physical Activity Vital Sign, 
Physical Activity Readiness Questionnaire and Exercise Stages of Change model, 
98.02%, 96.55% and 60.92%, of them, respectively, do not use the corresponding tool. 
When asked, what tools practitioners are using to accomplish these steps, an 
overwhelming majority of write in responses listed a variation of informal conversation 
without documentation. The lack of use of these tools, may be related to the lack of 
awareness of their existence.  
The responses from section three suggest that doctors and non-doctor primary care 
practitioners are currently executing the steps of the Exercise is Medicine® initiative at 
the same rate. In section four, respondents were asked if they felt that it was within their 
scope of practice to execute each individual step of the 5-step process during office visits. 
In the final question of the section, respondents were asked if they felt it was within their 
scope of practice to execute all 5 steps of the 5-step process during all office visits. 
Significant differences were found between doctors and non-doctors for each question, 
where doctors were less likely to agree that each step, or all steps, were within the scope 
of their practice. The exception was question 52, in which respondents were asked if it 
was within their scope of practice to refer patients to exercise professionals, when they 
deem it appropriate. Though the average response to this question was not statistically 
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different, doctors “somewhat agreed” (2.59) whereas non-doctors “agreed” (2.47). 
Though doctors agreed less than non-doctors for each question in section four, both 
groups did agree that it is within their scope of practice to assess patient physical activity 
level, assess patient physical ability level and refer to exercise professionals. However, 
doctors “neither agree or disagree” that the steps of behavioral counseling and 
handwriting prescriptions, are within their scope of practice. Further, doctors “somewhat 
disagree” that executing all five steps of the 5-step process is within their scope of 
practice. These findings suggest that doctors do not necessarily believe that the 5-step 
process proposed by the Exercise is Medicine® initiative is within their scope of practice. 
These finding are of great concern, as under its current construction, the implementation 
of the Exercise is Medicine® 5-step process is dependent on primary care physicians.  
It should be noted that we received four emails objecting to the wording of the questions 
in the fourth section of the survey, all from medical doctors. The questions in this section 
purposefully included the phrase “during all office visits” as that is the mandate of the 
Exercise is Medicine® initiative; except in the case of the fifth step (referral to exercise 
professionals), as this step is recommended to be executed only when deemed necessary. 
All four of the emails we received stated that this wording forced them to change their 
answers from some form of agreement to some form of disagreement. Further, three of 
the four emails also included a suggested compromise, in which practitioners be asked to 
perform the 5-step process annually as opposed to at every visit. Below, a quote from one 
of the respondents: 
   83 
 
“The survey may not reflect providers’ view of the importance of exercise.  The use of 
‘all clinic visits’ is not appropriate or practical. No provider will, or should, assess 
exercise at all, or even most, visits. You may want to change the wording to something 
like “all routine annual exams or annual check-ups”. Even then, 5-10 minutes to discuss 
only exercise is a big ask, even if important. Remember that these visits may only be 
scheduled for 20-30 minutes and includes time for rooming. Exercise is only part of a 
larger picture of health.”  
While four emails are a small percentage (3.8%) of the total responses (104), it is 
reasonable to assume that other respondents had similar feelings, but did not take the time 
to reach out. These unexpected responses indicate that a move, on the part of the Exercise 
is Medicine® initiative, to an annual strategy may improve practitioner attitudes towards, 
and thus compliance with, the initiative.  
The results of this survey are limited by a lack of random sampling for the midwestern 
group of practitioners. Though what originally appeared to be a geographical bias, was 
found to be a difference related to medical degree status. Another limitation was the 
failure to foresee and control for the objection to the wording of the questions in section 
four. Though the wording of the questions was purposeful, follow up questions aimed at 
delineating a respondents’ specific rationale for agreement or disagreement would have 
been illuminating. Lastly, this survey was limited by a low response rate. Though the 
response rate was in the range that can be expected for a single email distribution, more 
funding would have allowed for follow up emails, and likely would have improved the 
response rate. 
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Conclusion 
To our knowledge this is the first survey of primary care practitioners with the aim of 
assessing their familiarity with, current implementation of, and attitudes towards, the 
Exercise is Medicine® initiative. Our findings suggest that primary care practitioners are 
largely unaware of the Exercise is Medicine® initiative and they do not feel that it is 
within their scope of practice. However, they do feel that it would have only a positive 
impact on population physical activity levels. Importantly, doctors are less likely than 
non-doctors to agree that they should be executing all of the steps of the 5-step process at 
every office visit. Based on these findings additional efforts to publicize the Exercise is 
Medicine® initiative is imperative. A campaign directed at educating primary care 
practitioners appears necessary, as so few practitioners are aware of the initiative. 
Further, steps towards reducing the amount of time required of primary care practitioners 
should be made, as this is a chief complaint. These steps should include a streamlined 
version of the 5-step process as well as transitioning the 5-step process to annual use, 
aligning with the attitudes of primary care physicians. The disconnect between primary 
care practitioner attitudes and the current construction of the EIM® strategy warrants an 
investigation of the 5-step process, along with recommended updates. 
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Chapter 5. 
A Critical Evaluation of the Exercise is Medicine® 
Initiative and Proposed Amendments 
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Abstract 
Purpose 
The purpose of this editorial is to critically review the current Exercise is Medicine® 
(EIM) strategy to increase population physical activity through primary care practitioner 
intervention. The EIM® was established in 2007 by the American College of Sports 
Medicine (ACSM) and little has been done in an effort to assess the efficacy of the 5-step 
strategy that is currently in place. 
 
Critical Evaluation 
A critical review of the EIM® initiative and its 5-step process finds a dearth of direct and 
substantive evidence in support of its current construction. Individually, the steps of the 
5-step EIM® process, and the tools associated with them, have not been shown to be 
implemented in practice or effective. The little evidence available to quantify primary 
care practitioners’ awareness and use of the process, in the practical clinical setting, 
suggests that it has not been well implemented and is not well received.  
 
Proposed Amendments 
The Physical Activity Vital Sign (PAVS) and Physical Activity Readiness Questionnaire 
(PAR-Q) should be required within the electronic medical record systems of all hospitals 
and clinics nationally. Primary care practitioners should be responsible for assessing 
patient activity levels and ability through these tools at every office visit. They should 
then refer patients to exercise professionals at their discretion. To facilitate this referral 
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process it should be the responsibility of EIM® planners to develop an effective and easy 
to use referral network of exercise professionals. Further, it is the responsibility of the 
EIM® to increase visibility of this amended strategy, as well as to create surveillance 
system with the purpose of monitoring the efficacy and implementation of said strategy.   
 
Conclusion 
The current version of the EIM® strategy relies too heavily upon the primary care 
practitioner. Of chief concern are the lack of perceived time available and the lack of 
support for the current strategy, by the primary care practitioner. The proposed 
amendments provided herein are directed at better positioning both the primary care 
practitioner and the EIM® in order to more effectively utilize resources, lending to 
increased implementation and efficacy. 
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Introduction 
The physiological benefits of exercise, particularly aerobic exercise, related to disease 
prevention and treatment, are clear. Further, economic analysis of the potential impact of 
exercise on the healthcare system support the use of exercise prescription in the clinical 
setting (Rourk, Abraham, et al., 2018). Despite this understanding, the implementation of 
exercise as a preventative and treatment intervention in the healthcare system is largely at 
a standstill. The Exercise is Medicine® (EIM®) Initiative, established in 2007 by the 
American College of Sports Medicine (ACSM), was developed to take on the challenge 
of bridging the gap between our understanding of the potential impact of exercise as 
medicine and its use in practice. After more than a decade as the champion of this 
movement, the EIM® initiative is due for a critical evaluation. 
The EIM® initiative has remained unchallenged since its inception. There have been 
many editorials in which “calls to action” have been made in support of the initiative with 
little in the way of push back, potentially due to a lack of meaningful research on the 
topic. From a review of scholarly material related to the EIM® initiative, it appears that 
most researchers and medical professionals are theoretically supportive. However, 
despite this support, there is little evidence that the proposed strategy has been 
implemented in practice, much less effective. 
The strategy outlined by the EIM® Healthcare Providers’ Action Guide (American 
College of Sports Medicine, 2016), an ACSM publication, consists of five steps to be 
carried out by the primary care practitioner. Also, the action guide encourages primary 
care practitioners to generally promote physical activity in the clinic setting by, “walking 
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the walk”, i.e. self-involvement in physical activity and leading by example. According to 
the Action Guide, the 5-step process for healthcare providers to follow during all routine 
office visits is as follows, 1) assess patient physical activity levels, using the Physical 
Activity Vital Sign (PAVS), 2) assess patient physical activity ability, using the Physical 
Activity Readiness Questionnaire (PAR-Q), 3) counsel patients to increase physical 
activity, utilizing the Exercise Stages of Change model, 4) prescribe physical activity to 
patients using handwritten prescriptions, and 5) provide patients with referrals to exercise 
professionals when deemed necessary.   
 
Critical Evaluation 
Step 1: Assess Patient Physical Activity Levels Using the PAVS Tool  
The PAVS tool consists of two questions, 1) “On average, how many days per week do 
you engage in moderate to strenuous exercise (like a brisk walk)?”, and 2) “On average, 
how many minutes do you engage in exercise at this level?” (American College of Sports 
Medicine, 2016). In an effort to validate the Physical Activity Vital Sign Coleman et al. 
(2012) found that the results from a large-scale implementation of the Physical Activity 
Vital Sign, into the electronic medical records system of the Kaiser Permanente 
healthcare system, were similar to the results of national surveys related to physical 
activity levels. This work showed that after a period of just one and a half years, it was 
possible to implement this tool into the electronic medical records system of 86% of 
patients within the system. Further, works have found a statistically significant, though 
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clinically non-significant, relationship between the use of the PAVS tool and the outcome 
measures, weight loss and HBa1C, over time (Grant et al., 2014). 
Though the PAVS tool was validated for use in the healthcare system, and found to be 
associated with statistically significant changes in weight loss and HBa1C measures, the 
differences were not clinically significant (Grant et al., 2014). Statistical significance of 
non-clinically significant changes in weight loss and HBa1C measures was likely a result 
of large power due to a large sample size, as over 1.5 million visits by 696,267 adults to 
1,196 primary care providers were studied.  
The use of the PAVS tool was within the Kaiser Permanente healthcare system, appears 
to be unique, as a recent national survey found that 97.12% of primary care practitioners 
assess patient physical activity levels in greater than 1% of their patient populations 
(Rourk, Olson, & Snyder, 2018). However, of those that do assess activity levels, 98.02% 
do not use the PAVS tool. The most common approach to physical activity level 
assessment was informal conversation without record keeping. 
 
Step 2: Assess Patient Physical Activity Ability Using the PAR-Q Tool 
The PAR-Q is a seven question screening tool used to determine whether or not patients 
have potential for negative heart related and/or musculoskeletal outcomes during 
engagement in physical activity (American College of Sports Medicine, 2016). A patient 
that answers “no”, to all seven questions is cleared for moderate intensity physical 
activity. A “yes” answer to any question is an indication that the patient is potentially at 
risk for a negative outcome from engagement in physical activity and clinicians are 
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advised to use their professional judgement in the prescription of physical activity in 
these cases. 
According to survey, 83.65% of primary care practitioners assess physical activity ability 
level in at least 1% of their patient populations. However, similar to the PAVS tool, 
96.55% of those practitioners that do assess physical activity level do not use the PAR-Q, 
again informal conversation without documentation was the most common reported 
method. 
Similar to the PAVS tool, the PAR-Q is not meant to, and has not been demonstrated to, 
affect physical activity behavior of patients, rather these tools are designed to assess 
physical activity levels and ability, respectively. 
 
Step 3: Utilize Behavior Change Counseling Strategies Including the Exercise Stages 
of Change Questionnaire  
The Exercise Stages of Change Questionnaire consists of five questions and is used to 
determine the “Stage of Change” that a patient is currently in (American College of 
Sports Medicine, 2016). The stages of change model stems from the transtheoretical 
model of behavior change pioneered by James O. Prochaska and Carlo Di Clemente in 
the late 1970’s and early 1980’s (Glanz et al., 2008). The model, amended for use within 
the EIM® initiative, consists of five distinct stages of change ranging from 
precontemplation, the patient has no intention of becoming physically active, to 
maintenance, the patient has met the physical activity recommendations regularly for six 
consecutive months. This model was born from smoking cessation research and has been 
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applied to multiple behavior change domains since. This is one of the many parallel 
approaches taken, between the fight against smoking and the fight against physical 
inactivity. 
As it applies to physical activity, there is not a clear positive relationship between 
behavior counseling strategies and actual behavior change. AuYoung et al. (2016) states 
that “Findings on the impact of physical activity interventions in primary care have been 
mixed, due to insufficient follow-up or a lack of clarity about intervention intensity”. 
Similarly, Eden, Orleans, Mulrow, Pender and Teutsch (2002) state that “Evidence is 
inconclusive that counseling adults in the primary care setting to increase physical 
activity is effective.” It is worth noting that the “intensity” of behavior change counseling 
strategies found in the literature, and commented on by AuYoung et al. (2016) and Eden 
et al. (2002) is far greater than the proposed 3-5 minute session in which counseling is 
one of five steps. 
In its current form, the 5-step process of the EIM® initiative, relies heavily upon the 
Exercise Stages of Change behavior change counseling strategy to affect patient physical 
activity behavior. However, there is not enough evidence to conclude that this type of 
counseling strategy is effective. Further, of the 83.65% of primary care practitioners that 
self-reported to use behavioral counseling strategies directed at increasing physical 
activity with at least 1% of their patient populations, only 39.08% use the Exercise Stages 
of Change Model. Motivational interviewing techniques and informal conversation were 
the two most common methods reported. 
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Step 4: Provide Handwritten Exercise Prescriptions to Patients 
The EIM® process asks primary care practitioners to give handwritten prescriptions for 
exercise to patients. This directive is based on the findings from a randomized controlled 
trial with a six week follow up, in which handwritten prescriptions were found to be 
superior to simple verbal advice in affecting physical activity levels (Swinburn, Walter, 
Arroll, Tilyard, & Russel, 1998). Not considered in this trial are the motivations and 
attitudes of the primary care practitioners tasked with this directive. In a survey, primary 
care practitioners, on average, “did not agree or disagree” with a statement that read 
“Primary care practitioners should be providing written prescriptions for physical activity 
during all office visits, it is within their scope of practice.” (Rourk, Olson, et al., 2018). In 
the same survey, 62.50% of respondents self-reported that they never provide patients 
with handwritten prescriptions for physical activity. This evidence demonstrates that 
primary care practitioners are not eager to provide handwritten prescriptions for physical 
activity. 
Similar to step three, step four, of the 5-step process of the EIM® initiative, is directed at 
changing patient physical activity behavior. Though there is evidence to support its 
efficacy, there is also evidence that suggests it will be difficult to implement in the 
primary care setting, primarily due to resistance from primary care practitioners. 
 
Step 5: Provide Patients with Referrals to Exercise Professionals 
Though it seems logical to refer patients in need of exercise to exercise professionals, this 
is a step that seems to be outside of clinical norms. The EIM® action guide holds primary 
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care practitioners responsible for cultivating their own network of exercise professionals. 
Three pages of the guide are dedicated to the steps required to develop this network. 
Interestingly, when surveyed, primary care practitioners agreed with the statement 
“Primary care practitioners should be referring patients to exercise professionals when 
they deem it necessary, it is within their scope of practice.”, however, 45% of the same 
practitioners admitted to never referring a patient to an exercise professional and a 
combined 91% referred less than 20% of their patients to exercise professionals. 
As lack of time and other resources is a primary perceived barrier to the implementation 
of physical activity intervention by primary care practitioners (Huijg et al., 2015), adding 
the task of developing a network of exercise professionals will likely dissuade many 
practitioners from executing this step of the EIM® process. 
 
Summary 
Individually, the steps of the 5-step EIM® process, and the tools associated with them, 
have not been shown to be implemented in practice or effective. Overall, little is known 
about the implementation and efficacy of the EIM® initiative as there is little data that 
directly reports outcomes related to these areas of interest. What data is available, does 
not support the notion that the initiative is being executed in practice. In 1999, eight years 
prior to the inception of the EIM® initiative, Wee et al. (1999) reported that 34% of 
patients that had seen a doctor within the last twelve months reported receiving exercise 
related counseling. Thirteen years later (data from four years after the start of the 
initiative) Barnes and Schoenborn (2012) reported that 32.4% of patients reported the 
   95 
 
same result. This lack of change in exercise related counseling implies that the EIM® 
initiative is having little impact on the actions of primary care practitioners, who are 
integral to its implementation.  
In a survey of primary care practitioners it was shown that only 5.77% of respondents 
were aware of the EIM® initiative, its purpose and the 5-step process and a startling 
68.27% of respondents had never heard of the initiative (Rourk, Olson, et al., 2018). 
Further, primary care practitioners responded neutrally when asked if they felt that the 5-
step EIM® process was within their scope of practice. When analyzed separately, 
physicians “slightly disagreed” with the same question. 
A critical review of the EIM® initiative and its 5-step process finds a dearth of direct and 
substantive evidence in support of its current construction. The little evidence available to 
quantify primary care practitioners’ awareness and use of the process, in the practical 
clinical setting, suggests that it has not been well implemented and is not well received. 
Based on these findings, it is not clear how this model has garnered such unimpeded 
support in the academic realm. 
 
Proposed Amendments 
A critical evaluation of the current EIM® model necessitates amendments to the model. 
This section details these amendments while providing evidence for their proposal. A 
summary of the Amended EIM® strategy can be found in Figure 11. 
It has been shown that the PAVS questionnaire can be integrated into the electronic 
medical record system of a large healthcare system (Coleman et al., 2012), a strategy that 
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can likely be used for the implementation of the PAR-Q, as well. It is recommended that 
both of these tools be implemented into the electronic medical records systems in all 
hospitals and clinics. In this way, primary care staff will be forced to “check the boxes” 
of the PAVS and PAR-Q during all routine check-ups, in the same way that patient 
weight is recorded and blood pressure taken before an examination. This addition to 
regular tasks will realistically take no more than one to two minutes of total staff time, as 
these tests are comprised of a combined 9, short answer (less than three words), 
questions. This amendment accomplishes the task of monitoring patient physical activity 
levels and ensuring safe participation. It also serves to reduce the time commitment of 
primary care personnel.  
Physical activity behavior change counseling strategies have not been demonstrated to be 
effective in the clinical setting (AuYoung et al., 2016; Eden et al., 2002). Of concern in 
the literature, is the intervention intensity, or number and duration of meetings between 
doctor and patient, required to elicit a meaningful change in behavior (Grossmann et al., 
2010). For example, a systematic review and meta-analysis of physical activity 
interventions utilizing strategies aimed at changing self-efficacy, the underlying principle 
of the Exercise Stages of Change model, found a small but significant effect (d= 0.16, p < 
0.001) of interventions on self-efficacy (Ashford, Edmunds, & French, 2010). However, 
75% of the reviewed studies lasted six or more weeks and 60% of the reviewed studies 
included six or more sessions. Meanwhile, primary care practitioners, in an unsolicited 
email response to a recent survey, suggested that the current EIM® strategy be amended 
to call for only once annual implementation. This evidence demonstrates that even small 
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effects on self-efficacy require relatively high-intensity behavior counseling strategies, 
the likes of which, primary care practitioners are unwilling to undertake. For these 
reasons it is recommended that this step be removed, in order to lessen the burden placed 
on the primary care practitioner.   
Although handwritten prescriptions have been demonstrated as being superior to verbal 
advice alone in affecting physical activity behavior, primary care practitioners do not 
agree or disagree that it is within their scope of practice to write them (Rourk, Olson, et 
al., 2018). Again, the unwillingness of primary care practitioners to participate in a step 
of the EIM® process must be taken into account, as these practitioners are not required or 
incentivized to cooperate in any meaningful way. By including steps that are viewed by 
practitioners as outside of the scope of their practice, a prospective practitioner is likely 
to “throw the baby out with the bathwater” and disregard all of the steps of the 5-step 
EIM® process entirely. It is recommended that this step be either removed completely, or 
made optional, so as not to alienate practitioners that feel that it is not within their scope 
of practice. 
The primary focus of the Amended EIM® strategy should be directed at the development 
of an exercise professional referral network. This network must be trusted, effective and 
easy to use by practitioners and patients alike. When surveyed, primary care practitioners 
agreed that this step was within their scope of practice more than any other (Rourk, 
Olson, et al., 2018). However, 91.34% of the same practitioners referred less than 20% of 
their patients to exercise professionals, and 45.19% never referred patients. This evidence 
demonstrates that primary care practitioners are in favor of referring patients to exercise 
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professionals, but not willing to take the necessary steps to actually execute such a 
behavior. The EIM® seemed to be prepared for this barrier as evidenced by the length of 
the section in the Healthcare Providers’ Action Guide (American College of Sports 
Medicine, 2016) detailing how a primary care practitioner could go about developing a 
network of exercise professionals, to whom they could refer. In keeping with the strategy 
of reducing the time-related burden on practitioners, the steps required to develop and use 
a network of exercise professionals must be accomplished by a third party. In this case, it 
is recommended that the ACSM and EIM® be that third party. 
A secondary focus should be increasing visibility and awareness of the new Amended 
EIM® model. The finding that 68.27% of primary care practitioners have never heard of 
EIM® is unacceptable. Considerable resources need to be invested into increasing the 
visibility of the Amended EIM® strategy. Primary care practitioners need to be made 
aware of their responsibilities, the PAVS and PAR-Q questionnaires need to be required 
within the electronic medical record systems of all hospitals and clinics, and an easy to 
use and effective network of exercise professionals must be made readily available to 
practitioners and patients alike. 
Lastly, a system of surveillance dedicated to measuring outcomes related to the 
implementation of the EIM® will provide information useful for future amendments. 
Over a decade has passed since the inception of the EIM® and this is the first critical 
analysis to date. In the future, higher standards of accountability and measures of efficacy 
should be required to ensure efficient and effective implementation of the amended 
strategy. 
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Conclusion 
 The current version of the EIM® strategy relies too heavily upon the primary care 
practitioner. Of chief concern are the lack of perceived time available and the lack of 
support for the current strategy, by the primary care practitioner. After reviewing the 
evidence, it appears that the primary practitioner is well positioned to execute only a 
portion of the current 5-step EIM® strategy. We suggest that the ACSM EIM® initiative 
focus on soliciting primary care practitioners to assess patient physical activity levels and 
ability by imbedding the PAVS and APR-Q into the electronic medical records systems 
of hospitals and clinics nationwide. Upon assessment, practitioners should then refer 
patients to appropriate exercise and medical professionals found within a newly 
developed exercise professional referral network. Development of this referral network 
and pathway should be the responsibility of the EIM® planners, as not to burden 
practitioners. Increasing visibility and awareness of the Amended EIM® strategy, should 
become a major focus of the EIM® as well. Lastly, a system of surveillance dedicated to 
monitoring the implementation and efficacy of the EIM® strategy should be put in place, 
in order to provide planners with information as to optimize the strategy over time.  
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Chapter 6. 
Overall Conclusions and Future Directions 
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Increased population physical activity has the potential to significantly impact both the 
healthcare system as a whole as well as individual well-being. The economic analysis 
presented in this dissertation, provides insight into the scope of this effect. Total 
diagnosed clinical cases of cardiovascular disease, stroke, type II diabetes mellitus, 
Alzheimer’s disease, breast cancer, colon cancer and depression attributable to physical 
inactivity are estimated at between 19 and 28 million and total direct medical costs 
attributable to physical inactivity are estimated between USD 109 and 155 billion, 
annually. These costs represent between 3.3 and 4.7% of total annual direct medical 
spending in the United States. Clinicians and policymakers alike can expect a reduction 
in diagnosed cases of over a quarter of a million and savings in direct medical costs of 
over USD 1 billion, for every 0.96 absolute percentage point change in the proportion of 
individuals that meet the weekly exercise recommendations. 
These clinical and economic benefits provide a rationale for the implementation of a 
population level intervention directed at increasing the proportion of Americans that meet 
the weekly physical activity recommendations. One such intervention currently exists, the 
ACSM EIM® initiative. The proposed strategy by the EIM® relies heavily on the 
implementation of a 5-step process by primary care practitioners. Little research has been 
performed to investigate whether or not this proposed strategy has been implemented or 
made effective in practice, since its inception in 2007.  
The survey of primary care practitioner’s knowledge and understanding of the EIM®, 
presented in this dissertation demonstrate that primary care providers are unaware of the 
EIM® initiative and its 5-step process, do not currently implement the steps of the 
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process, and do not believe that said implementation is within their scope of practice. 
These findings combined with the integral nature of the primary care practitioner within 
the proposed EIM® strategy, warrant a critical review of the current EIM® strategy. 
The current EIM® strategy places too many demands on primary care practitioners. 
Further, individually, the steps of the current EIM® strategy have never been shown to 
affect physical activity behavior. For these reasons it is recommended that the current 
EIM® strategy be amended. The PAVS and PAR-Q should be required in the electronic 
medical record systems of all hospitals and clinics, and primary care physicians should 
refer patients to exercise professionals when deemed necessary. To facilitate the referral 
of patients to exercise professionals, the ACSM EIM® planners should invest a bulk of 
their resources in to the development of a referral network that is easy to use for both 
practitioners and patients alike. The lack of such a network is likely a barrier to the 
implementation of the referral process, as a majority of practitioners agree that they 
should be referring patients to exercise professionals, however, very few actually are. 
Lastly, the EIM® must invest considerable effort and resources into visibility.  
The primary future directive stemming from this dissertation is the development of a 
feasible and effective exercise professional referral network. Future study is required to 
determine the necessary components for such a network as well as to ascertain and 
overcome the logistical aspects of its implementation. 
Secondarily, efforts need to be made to increase the visibility of the Amended EIM® 
strategy outside of exercise professionals, with special focus on primary care 
practitioners. Without awareness and understanding no proposed strategy will work. 
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Thirdly, continual surveillance of outcomes related to the amended EIM® model are 
warranted. This dissertation is the first attempt in over a decade to assess the efficacy of 
the EIM® model. A system of surveillance is necessary to provide planners and decision 
makers with data helpful in optimizing the future direction of the strategy. 
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Table 1. Retrieved Data and Sources
Disease Type Prevalence Cause of Death Rank DMC (Billions of USD) Relative Risk (95% CI)
Cardiovascular Disease 85,600,0003 17 $187.683 0.86 (0.77-0.96)11 
Type II Diabetes Mellitus 27,010,0003 77 $183.983 0.65 (0.59–0.71)12
Depression 16,100,0006 10 (Suicide)7 $103.398 0.67 (0.49-0.91)13
Alzheimer's Disease 5,300,0004 67 $77.719 0.55 (0.36–0.84)14
Breast Cancer 3,461,0005 2 (All Cancer)7 $18.385 0.88 (0.85–0.91)15
Colon Cancer 1,216,0005 2 (All Cancer)7 $15.755 0.88 (0.86–0.91)16
Stroke 6,600,0003 57 $18.353 0.843 (0.779-0.918)17
Total 145,287,000 605.24  
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Table 2. Relative Risk of Disease Given Either Physical Activity or Pharmacological Intervention
Condition Study Type
# of 
Studies 
N Intervention Type Authors Year Relative Risk (95% C.I.) Intervention Group Comparison Group
Cardiovascular Disease Meta-Analysis 26 513,472 Physical Activity Sofi, Capalbo, 
Cesari, Abbate 
and Gensini20
2008 0.73 (0.66–0.80) High PA Low PA
0.88 (0.83–0.93) Moderate PA Low PA
Meta-Analysis 33 NA Physical Activity Sattelmair, 
Pertman, Ding, 
Kohl III, Haskell, 
Lee11
2011 0.80 (0.74–0.88) 300 min/week of moderate-
intensity PA 
No PA
0.86 (0.77–0.96) 150 min/week of moderate-
intensity PA 
No PA
Meta-Analysis 21 >650,000 Physical Activity Li and Siegrist21 2012 0.79 (0.73-0.85) High PA (Men) Low PA (Men)
0.85 (0.77-0.93) Moderate PA (Men) Low PA (Men)
0.71 (0.65-0.77) High PA (Women) Low PA (Women)
0.78 (0.72-0.85) Moderate PA (Women) Low PA (Women)
Meta-Analysis 23 790,000 Physical Activity Li, Loerbroks and 
Angerer22
2013 0.79 (0.73-0.85) High PA Low PA
0.71 (0.65-0.77) Moderate PA Low PA
Meta-Analysis 147 464,000 Pharmacological Law, Morris, & 
Wald23
2009 0.85 (0.81-0.89) All Classes of Blood Pressure 
Medication
Placebo
Stroke Meta-Analysis 13 255,873 Physical Activity Diep, Kwagyan, 
Kurantsin-Mills, 
Weir, 
Jayam,Trouth24
2010 0.81 (0.77-0.84) High PA Low PA
0.89 (0.86-0.93) Moderate PA Low PA
Meta-Analysis 21 >650,000 Physical Activity Li and Siegrist21 2012 0.71 (0.60-0.84) High PA (Men) Low PA (Men)
0.89 (0.82–0.97) Moderate PA( Men) Low PA (Men)
0.73 (0.68-0.78) High PA (Women) Low PA (Women)
0.83 (0.67–1.03) Moderate PA (Women) Low PA (Women)
Meta-Analysis 23 790,000 Physical Activity Li, Loerbroks and 
Angerer22
2013 0.72 (0.58-0.90) High PA Low PA
0.79 (0.72-0.88) Moderate PA Low PA
Meta-Analysis 26 1,573,231 Physical Activity Kyu, Bachman, 
Alexander, 
Mumford, Afshin, 
Estep, Veerman, 
Delwiche, 
Iannarone, Moyer, 
Cercy, Vos, 
Murray, 
Forouzanfar17
2016 0.736 (0.659-0.811) 8,000+ MET min/wk <600 MET min/wk
0.810 (0.690-0.937) 4000-7999 MET min/wk <600 MET min/wk
0.843 (0.779- 0.918) 600-3999 MET min/wk <600 MET min/wk
Meta-Analysis 147 464,000 Pharmacological Law, Morris, & 
Wald23
2009 0.73 (0.66-0.80) All Classes of Blood Pressure 
Medication
Placebo
Type II Diabetes Mellitus Systematic Review 81 >1,800,000 Physical Activity Aune, Norat, 
Leitzmann, 
Tonstad, and 
Vatten12
2015 0.65 (0.59-0.71) High Total PA Low Total PA
0.74 (0.70-0.79)  High Leisure Time PA Low Leisure Time PA
0.61 (0.51-0.74) High Vigorous PA Low Vigorous PA
0.68 (0.52-0.90) High Moderate PA Low Moderate PA
0.66 (0.47-0.94) High Low Intensity PA Low Low Intensity PA
0.85 (0.79-0.91) High Walking Low Walking
0.72 (0.57-0.91) High Resistance Exercise Low Resistance Exercise
0.85 (0.79-0.92) High Occupational PA Low Occupational PA
0.45 (0.29-0.70) High Cardiorespiratory 
Fitness
Low Cardiorespiratory 
Fitness
Systematic Review 10 301,221 Physical Activity Jeon, Hu, Lokken 
and van Dam25
2007 0.69 (0.58-0.83) Regular Participation in 
Moderate PA
Sedentary
0.70 (0.58-0.84) Regular Walking No Walking
Consensus Workshop 11 15,772 Lifestyle or 
Pharmacological
Alberti, Zimmet 
and Shaw26
2007 0.37 (NA) Lifestyle Placebo
0.58 (NA) Lifestyle Placebo
0.42 (NA) Lifestyle Placebo
0.42 (NA) Lifestyle Placebo
0.37 (NA) Lifestyle Placebo
0.72 (NA) Lifestyle Placebo
0.69 (NA) Metformin Placebo
0.74 (NA) Metformin Placebo
0.45 (NA) Troglitazone Placebo
0.25 (NA) Troglitazone Placebo
0.75 (NA) Acarbose Placebo
0.63 (NA) Orlistat Placebo
0.40 (NA) Rosiglitazone Placebo
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Metaepidemiological 
Study
305 339,274 Physical Activity vs. 
Pharmacological
Naci and 
Loannidis27
2013 0.22 (0.02-1.18) PA AGIs
2.67 (0.41-36.39) PA Biguanides
0.73 (0.14-1.96) PA ACE Inhibitors
0.69 (0.10-2.52) PA Glinides
Depression Systematic Review 
and Meta-Analysis
10 758 Physical Activity Silveira, Moraes, 
Oliveira, 
Coutinho, Laks, 
and Deslandes13
2013 1.49 (1.10-2.03) Control PA
1.14 (0.97-1.35) Control PA
Review of Meta-
Analyses
833 48,207 Physical Activity Wegner, Helmich, 
Machado, Nardi, 
Arias-Carrion and 
Budde28
2014 0.56 (0.31) Effect Size The Effect of Physical 
Activity on Depression
Alzheimer's Disease Sysematic Review and 
Meta-Analysis
37 NA Physical Activity Blondell, 
Hammersley-
Mather and 
Veerman29
2014 0.86 (0.76-0.97)a High PA Low PA
0.65 (0.55-0.76)b High PA Low PA
Systematic Review 16 163,797 Physical Activity Hamer and Chida14 2008 0.72 (0.60-0.86)a High PA Low PA
0.55 (0.36-0.84) High PA Low PA
Meta-Analysis 3 3,574 Pharmacological Diniz, Pinto Jr., 
Gonzaga, 
Guimaraes, Gattaz 
and Forlenza31
2009 0.75 (0.65-0.87) Cholinesterase Inhibitors Placebo
Breast Cancer Meta-Analysis 31 63,786 Physical Activity Wu, Zhang and 
Kang15
2013 0.88 (0.85-0.91) High PA Overall Low PA Overall
0.90 (0.83-0.97) High Occupational PA Low Occupational PA
0.87 (0.84-0.91) High Non-Occupational PA Low Non-Occupational PA
0.89 (0.85-0.92) High Recreational PA Low Recreational PA
0.89 (0.83-0.95) High Household PA Low Household PA
0.88 (0.81-0.96) High Walking Low Walking
0.97 (0.94-0.99) High Moderate PA Low Moderate PA
0.86 (0.82-0.89) High Vigorous PA Low Vigorous PA
Benefit/Risk 
Assesment
2 657 Pharmacological Freedman, Yu, 
Gail, Constantino, 
Graubard, Vogel, 
Anderson and 
McCaskill-
Stevens32
2011 0.59 (0.43-0.82) Raloxifenec Placebo
0.51 (0.39-0.66) Tamoxifenc Placebo
.
Colon Cancer Meta-Analysis 30 3,970,339 Physical Activity Robsahm, Aagnes, 
Hjartaker, 
Langseth, Bray and 
Larsen33
2013 0.76 (0.70-0.83)d High PA Low PA
0.77 (0.71-0.83)e High PA Low PA
Meta-Analysis 21 11,093 Physical Activity Johnson, Wei, 
Ensor, Smolenski, 
Amos, Levin and 
Berry16
2013 0.88 (0.86-0.91)f High PA Low PA
Meta-Analysis 52 NA Physical Activity Wolin, Yan and 
Lee35
2009 0.76 (0.72-0.81) High PA Overall Low PA Overall
0.76 (0.71-0.82) High PA Men Low PA Men
0.79 (0.71-0.88) High PA Women Low PA Women
Meta-Analysis 4 2,967 Pharmacological Cole, Logan, 
Halabi, 
Benamouzig, 
Sandler, Grainge, 
Chaussade and 
Baron36
2009 0.83 (0.72-0.96)f Aspirin Placebo
aRelative risk for dementia
bRelative risk for cognitive decline
cAssociated with toxic side effects, only used in patients already suffering from breast cancer
dRelative risk for cancer of the proximal colon
eRelative risk for cancer of the distal colon
fRelative risk for colorectal cancer  
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Table 3. Population Attributable Risk, Total Cases and Total DMC Attributable to Physical Inactivity
Disease Type  PAR (95% CI)
Total Cases Attributable  
to Physical Inactivity
Total DMC Attributable               
to Physical Inactivity                         
(Billions of USD) PAR (95% CI)
Total Cases Attributable  
to Physical Inactivity
Total DMC Attributable               
to Physical Inactivity                         
(Billions of USD)
Cardiovascular Disease 12.64% (3.49-20.78%) 10,819,840 $23.72 8.29% (2.21-14.08%) 7,096,240 $15.56
Type II Diabetes Mellitus 32.39% (27.04-38.41%) 8,748,539 $59.59 23.04% (18.80-28.05%) 6,223,104 $42.39
Depression 30.70% (8.29-48.22%) 4,942,700 $31.74 21.68% (5.35-36.79%) 3,490,480 $22.41
Alzheimer's Disease 42.57% (14.66-61.67%) 2,256,210 $33.08 31.66% (9.69-50.14%) 1,677,980 $24.60
Breast Cancer 11.23% (8.29-13.99%) 388,670 $2.06 7.33% (5.35-9.23%) 253,691 $1.35
Colon Cancer 11.23% (8.29-13.99%) 136,557 $1.77 7.33% (5.35-9.23%) 89,133 $1.15
Stroke 14.39% (7.45-20.43%) 949,740 $2.64 9.50% (4.78-13.83%) 627,000 $1.74
Total 28,242,256 $154.61 19,457,628 $109.21
Calculation based on NHIS Survey Data (Prf= .565)                      Calculation based on NHANES Accelerometry Data (Prf= .904)                      
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Table 4. A Summary of the Potential Cases Prevented and Direct Medical Cost Saving for Each Analysis
Disease Type
SurveyData Accel10% Accel4.4 SurveyData Accel10% Accel4.4
Cardiovascular Disease 510,138 100,487 462,794 $1,118.49 $220.32 $1,014.69
Type II Diabetes Mellitus 379,838 63,032 292,515 $2,393.24 $397.15 $1,843.04
Depression 216,566 36,492 169,240 $1,390.73 $234.34 $1,086.82
Alzheimer's Disease 91,563 13,823 64,402 $1,342.51 $202.67 $944.28
Breast Cancer 18,414 3,670 16,891 $97.79 $19.49 $89.70
Colon Cancer 6,470 1,289 5,935 $83.80 $16.70 $76.87
Stroke 44,560 8,650 39,863 $123.89 $24.05 $110.83
Total 1,267,548 227,443 1,051,640 $6,550.45 $1,114.72 $5,166.22
Potential Clinical Cases Prevented Potential Direct Medical Cost Savings (Billions of USD) 
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Table 5. Descriptive Statistics
Overall Doctors Non-Doctors MN Non-MN
N = 104 N = 85 N = 19 N = 59 N = 45
Specialty
Family Practitioner 48 48 0 33 15
Pediatrician 23 23 0 15 8
Geriatrician 0 0 0 0 0
Internist 3 3 0 2 1
Obstetrician/Gynecologist 6 6 0 0 6
Nurse Practitioner 14 0 14 4 10
Physician’s Assistant 2 0 2 1 1
Other (Doctor) 5 5 0 3 2
Other (Non-Doctor) 3 0 3 1 2
Medical Doctor (MD) or Doctor of Osteopathy (DO)
MD 74 74 NA 48 26
DO 5 5 NA 2 3
DNA 6 6 NA 3 3
Percentage of Primary Care Patients Seen in Practice
0-25% 15 10 5 4 11
26-50% 4 1 3 0 4
51-75% 3 3 0 1 2
76-100% 82 71 11 54 28
Years in Practice
0-5 years 9 6 3 6 3
6-10 years 15 12 3 10 5
11-15 years 16 12 4 12 4
>15 years 64 55 9 31 33
Type of Practice
Solo Practice 8 7 1 0 8
Group Practice 69 58 11 48 21
Hospital 7 4 3 3 4
Academics 2 2 0 0 2
VA/ Government 5 5 0 1 4
HMO 4 4 0 3 1
Other 9 5 4 4 5
Sex
Male 38 38 0 26 12
Female 66 47 19 33 33
Age
Average Age 52.27 51.64 54.79 49.70 55.14
Youngest 32 35 32 32 35
Oldest 78 78 68 76 78  
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Figure 1. Questions and Potential Answers 
Q48
Primary care practitioners should be assessing patient physical 
activity levels during all office visits, it is within their scope of 
1 Strongly agree
Q49
Primary care practitioners should be determining patient exercise 
ability during all office visits, it is within their scope of practice.
2 Agree
Q50
Primary care practitioners should be utilizing behavioral counseling 
strategies directed at increasing physical activity during all office 
visits, it is within their scope of practice.
3 Somewhat agree
Q51
Primary care practitioners should be providing written prescriptions 
for physical activity during all office visits, it is within their scope of 
4 Neither agree nor disagree
Q52
Primary care practitioners should be referring patients to exercise 
professionals when they deem it necessary, it is within their scope 
5 Somewhat disagree
Q53
Primary care practitioners should execute all 5 steps of the EIM 
process at every office visit, it is within their scope of practice.
6 Disagree
7 Strongly disagree
Questions Potential Responses
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Figure 2. Primary Care Practitioner Attitude Towards EIM®: Overall 
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Figure 3. Primary Care Practitioner Familiarity with EIM®: Before taking part in this 
survey, which of the following best describes your knowledge of the EIM® initiative? 
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Figure 4. Primary Care Practitioner Implementation of the EIM®: During routine office 
visits, with what percentage of patients do you… 
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Figure 5. Primary Care Practitioner Implementation of the EIM®: When you do assess 
patient activity levels, do you use the Physical Activity Vital Screen (PAVS)? 
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Figure 6. Primary Care Practitioner Implementation of the EIM®: When you do 
determine your patient's ability to exercise, do you use the Physical Activity Readiness 
Questionnaire (PAR-Q)? 
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Figure 7. Primary Care Practitioner Implementation of the EIM®: When you do use 
behavioral counseling strategies, do you use The Exercise Stages of Change Model? 
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Figure 8. If all five steps of the EIM® process were carried out by all primary care 
practitioners during all office visits, how would the physical activity level of the patient 
population be affected? 
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Figure 9. Primary Care Practitioners Attitude Towards EIM®: Doctor vs. Non-Doctor  
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Figure 10. Primary Care Practitioners Attitude Towards EIM®: MN vs. Non-MN  
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Figure 11. Comparison of the Proposed Amended EIM® Strategy and the Current EIM® Strategy 
Amended EIM® Strategy Current EIM® Strategy
Steps for Primary Care Practitioners Steps for Primary Care Practitioners
1) PAVS and PAR-Q required in Electronic Medical Record System 1) Assess patient physical activity levels, using the Physical Activity Vital Sign (PAVS)
2) Primary care practitioners refer patients to exercise professionals when deemed necessary* 2) Assess patient physical activity ability, using the Physical Activity Readiness Questionnaire (PAR-Q)
3) Counsel patients to increase physical activity, utilizing the Exercise Stages of Change model
Steps for ACSM and EIM® Planners 4) Prescribe physical activity to patients using handwritten prescriptions
1) Create a referral network of exercise professionals for primary care practitioners 5) Provide patients with referrals to exercise professionals when deemed necessary
2) Create awareness of the Amended EIM® strategy
*Necessary refers to any patient that does not meet the current weekly physical activity 
recommendations or is symptomatic of disease related to sedentary lifestlye  
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Section 1: Demographics 
 
Q16 What is your specialty? 
1. Family Practitioner 
2. Pediatrician 
3. Geriatrician 
4. Internist 
5. Obstetrician/Gynecologist 
6. Nurse Practitioner 
7. Physician’s Assistant 
8. Other (Please Describe) _______________ 
 
Q36 Are you a Medical Doctor (MD), or Doctor of Osteopathy (DO)? 
1. Medical Doctor (MD) 
2. Doctor of Osteopathy (DO) 
 
Q17 Please indicate the percentage of primary care patients in your practice? 
1. 0-25% 
2. 26-50% 
3. 51-75% 
4. 76-100% 
 
Q18 How long have you been in practice? 
1. 0-5 years 
2. 6-10 years 
3. 11-15 years 
4. >15 years 
 
Q19 Which of the following best describes your practice, or the practice that you are a 
part of? 
1. Solo Practice 
2. Group Practice 
3. Hospital 
4. Academics 
5. VA/ Government 
6. HMO 
7. Other (Please Describe) __________________________ 
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Q20 Are you male or female? 
1. Male 
2. Female 
 
Q21 What is your date of birth? (mm/dd/yyyy) ______________________________ 
 
Q33 What state do you practice in? State Initials ____________________ 
 
Section 2: Current Awareness 
 
Q34 Exercise is Medicine   
The purpose of the Exercise is Medicine (EIM) initiative is to make the scientifically 
proven benefits of physical activity the standard in the U.S. healthcare system. The vision 
of EIM is to have healthcare providers assess every patient's level of physical activity at 
every clinic visit, determine if the patient is meeting the U.S. National Physical Activity 
Guidelines and provide patients with brief counseling to help him/her meet the guidelines 
and/or refer the patient to either healthcare or community-based resources for further 
physical activity (PA) counseling. 
    The 5 Step EIM Process  The EIM model relies upon the implementation of a 5 step 
process, by primary care practitioners. This process is intended to be executed at every 
office visit and takes approximately 3-5 minutes. The steps are as follows.   
1. Assess the patient’s current activity levels using the Physical Activity Vital Sign 
(PAVS)   
2. Determine the patient’s ability to exercise using the Physical Activity Readiness 
Questionnaire (PAR-Q)   
3.Counsel the patient using behavioral counseling strategies and The Exercise Stages of 
Change questionnaire (ESC-Q)   
4. Provide a handwritten prescription for physical activity   
5. Provide the patient with a referral to an exercise professional, when necessary 
  
   Before taking part in this survey, which of the following options best describes your 
knowledge of the EIM initiative? 
1. I had never heard of EIM  
2. I had heard of EIM, but did not know its purpose or about the 5 step process  
3. I had heard of EIM, and knew about its purpose, but did not know the 5 step process  
4. I had heard of EIM, and knew about the 5 step process, but did not know about its 
purpose  
5. I had heard of EIM, and knew about its purpose and the 5 step process  
 
Section 3: Current Clinical Use 
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Q35 During routine office visits, in what percentage of patients do you assess their 
current activity levels?  
1. I never assess patient activity levels  
2. 1-20%  
3. 21-40%  
4. 41-60%  
5. 61-80%  
6. 81-100%  
 
Q38 When you do assess patient activity levels, do you use the Physical Activity Vital 
Screen (PAVS)? 
1. No  
2. Yes  
 
Q39 What type of screening tool or method do you use to assess patient activity levels? 
Please describe below. 
________________________________________________________________ 
 
Q36 During routine office visits, in what percentage of patients do you determine their 
ability to exercise?  
1. I never determine a patient's ability to exercise  
2. 1-20%  
3. 21-40%  
4. 41-60%  
5. 61-80%  
6. 81-100%  
 
Q40 When you do determine your patient’s ability to exercise do you use the Physical 
Activity Readiness Questionnaire (PAR-Q)? 
1. No  
2. Yes  
 
Q41 What type of screening tool or method do you use to determine a patient's ability to 
exercise? Please describe below. 
________________________________________________________________ 
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Q42 During routine office visits, with what percentage of patients do you use behavioral 
counseling strategies directed at increasing physical activity levels? 
1. I never use behavioral counseling strategies directed at increasing physical activity 
levels  
2. 1-20%  
3. 21-40%  
4. 41-60%  
5. 61-80%  
6. 81-100%  
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Q43 When you do use behavioral counseling strategies do you use The Exercise Stages 
of Change (i.e. Pre-contemplation, Contemplation, Preparation, Action, Maintenance)? 
1. No  
2. Yes  
 
Q44 What type of behavioral counseling strategy do you use directed at increasing the 
physical activity levels of your patients? Please describe below. 
______________________________ 
 
Q45 During routine office visits, with what percentage of patients do you provide a 
handwritten prescription for physical activity or exercise? 
1. I never provide patients with handwritten prescriptions for exercise  
2. 1-20%  
3. 21-40%  
4. 41-60%  
5. 61-80%  
6. 81-100%  
 
Q46 During routine office visits, what percentage of patients do you refer to exercise 
professionals? 
1. I never refer patients to exercise professionals  
2. 1-20%  
3. 21-40%  
4. 41-60%  
5. 61-80%  
6. 81-100%  
 
Q47    The 5 Step EIM Process   
The EIM model relies upon the implementation of a 5 step process, by primary care 
practitioners. This process is intended to be executed at every office visit and takes 
approximately 3-5 minutes. The steps are as follows.   
1. Assess the patient’s current activity levels using the Physical Activity Vital Sign 
(PAVS)   
2. Determine the patient’s ability to exercise using the Physical Activity Readiness 
Questionnaire (PAR-Q)   
3.Counsel the patient using behavioral counseling strategies and The Exercise Stages of 
Change questionnaire (ESC-Q)   
4. Provide a handwritten prescription for physical activity   
5. Provide the patient with a referral to an exercise professional, when necessary 
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During routine office visits, what percentage of patients do you execute all 5 steps of the 
EIM process with? 
1. I never execute all 5 steps of the EIM process with a patient  
2. 1-20%  
3. 21-40%  
4. 41-60%  
5. 61-80%  
6. 81-100%  
 
Section 4: Scope of Practice 
 
Q48 Primary care practitioners should be assessing patient physical activity levels during 
all office visits, it is within their scope of practice. 
1. Strongly agree  
2. Agree  
3. Somewhat agree  
4. Neither agree nor disagree  
5. Somewhat disagree  
6. Disagree  
7. Strongly disagree  
 
Q49 Primary care practitioners should be determining patient exercise ability during all 
office visits, it is within their scope of practice. 
1. Strongly agree  
2. Agree  
3. Somewhat agree  
4. Neither agree nor disagree  
5. Somewhat disagree  
6. Disagree  
7. Strongly disagree  
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Q50 Primary care practitioners should be utilizing behavioral counseling strategies 
directed at increasing physical activity during all office visits, it is within their scope of 
practice. 
1. Strongly agree  
2. Agree  
3. Somewhat agree  
4. Neither agree nor disagree  
5. Somewhat disagree  
6. Disagree  
7. Strongly disagree  
 
Q51 Primary care practitioners should be providing written prescriptions for physical 
activity during all office visits, it is within their scope of practice. 
1. Strongly agree  
2. Agree  
3. Somewhat agree  
4. Neither agree nor disagree  
5. Somewhat disagree  
6. Disagree  
7. Strongly disagree  
 
Q52 Primary care practitioners should be referring patients to exercise professionals 
when they deem it necessary, it is within their scope of practice. 
1. Strongly agree  
2. Agree  
3. Somewhat agree  
4. Neither agree nor disagree  
5. Somewhat disagree  
6. Disagree  
7. Strongly disagree  
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Q53 The 5 Step EIM Process   
The EIM model relies upon the implementation of a 5 step process, by primary care 
practitioners. This process is intended to be executed at every office visit and takes 
approximately 3-5 minutes. The steps are as follows.   
1. Assess the patient’s current activity levels using the Physical Activity Vital Sign 
(PAVS)   
2. Determine the patient’s ability to exercise using the Physical Activity Readiness 
Questionnaire (PAR-Q)   
3.Counsel the patient using behavioral counseling strategies and The Exercise Stages of 
Change questionnaire (ESC-Q)   
4. Provide a handwritten prescription for physical activity   
5. Provide the patient with a referral to an exercise professional, when necessary 
  
   Primary care practitioners should execute all 5 steps of the EIM process at every office 
visit, it is within their scope of practice. 
1. Strongly agree  
2. Agree  
3. Somewhat agree  
4. Neither agree nor disagree  
5. Somewhat disagree  
6. Disagree  
7. Strongly disagree  
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Q59 The 5 Step EIM Process   
The EIM model relies upon the implementation of a 5 step process, by primary care 
practitioners. This process is intended to be executed at every office visit and takes 
approximately 3-5 minutes. The steps are as follows.   
1. Assess the patient’s current activity levels using the Physical Activity Vital Sign 
(PAVS)   
2. Determine the patient’s ability to exercise using the Physical Activity Readiness 
Questionnaire (PAR-Q)   
3.Counsel the patient using behavioral counseling strategies and The Exercise Stages of 
Change questionnaire (ESC-Q)   
4. Provide a handwritten prescription for physical activity   
5. Provide the patient with a referral to an exercise professional, when necessary 
 
I feel that it is possible to effectively execute all 5 steps of the EIM process in 3-5 
minutes?   
  
1. Strongly agree  
2. Agree  
3. Somewhat agree  
4. Neither agree nor disagree  
5. Somewhat disagree  
6. Disagree  
7. Strongly disagree  
 
Q60 I would be more likely to execute all, or some, of the 5 step EIM process, if I were 
reimbursed through standard medical billing procedures. 
1. Strongly agree  
2. Agree  
3. Somewhat agree  
4. Neither agree nor disagree  
5. Somewhat disagree  
6. Disagree  
7. Strongly disagree  
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Section 5: Attitudes Towards Potential Efficacy 
 
Q58 The 5 Step EIM Process  The EIM model relies upon the implementation of a 5 step 
process, by primary care practitioners. This process is intended to be executed at every 
office visit and takes approximately 3-5 minutes. The steps are as follows.   
1. Assess the patient’s current activity levels using the Physical Activity Vital Sign 
(PAVS)   
2. Determine the patient’s ability to exercise using the Physical Activity Readiness 
Questionnaire (PAR-Q)   
3.Counsel the patient using behavioral counseling strategies and The Exercise Stages of 
Change questionnaire (ESC-Q)   
4. Provide a handwritten prescription for physical activity   
5. Provide the patient with a referral to an exercise professional, when necessary 
 
  
   If all 5 steps of the EIM process were carried out by all primary care practitioners 
during all office visits, how would the physical activity level of the patient population be 
affected? 
1. Greatly Increase  
2. Slightly Increase  
3. Neither Increase or Decrease  
4. Slightly Decrease  
5. Greatly Decrease  
 
 
 
 
 
 
 
